{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:35:06Z","timestamp":1772609706971,"version":"3.50.1"},"reference-count":247,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11010-022-04438-9","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T15:37:19Z","timestamp":1651160239000},"page":"2269-2296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Migraine signaling pathways: amino acid metabolites that regulate migraine and predispose migraineurs to headache"],"prefix":"10.1007","volume":"477","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-8343","authenticated-orcid":false,"given":"Roger Gregory","family":"Biringer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"issue":"8148","key":"4438_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/s0140-6736(79)92692-8","volume":"2","author":"MA Moskowitz","year":"1979","unstructured":"Moskowitz MA, Reinhard JF Jr, Romero J, Melamed E, Pettibone DJ (1979) Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet 2(8148):883\u2013885. https:\/\/doi.org\/10.1016\/s0140-6736(79)92692-8","journal-title":"Lancet"},{"issue":"2","key":"4438_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00004647-199902000-00001","volume":"19","author":"A May","year":"1999","unstructured":"May A, Goadsby PJ (1999) The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 19(2):115\u2013127. https:\/\/doi.org\/10.1097\/00004647-199902000-00001","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"4438_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00127893-200109000-00002","volume":"7","author":"SJ Tepper","year":"2001","unstructured":"Tepper SJ, Rapoport A, Sheftell F (2001) The pathophysiology of migraine. Neurologist 7(5):279\u2013286. https:\/\/doi.org\/10.1097\/00127893-200109000-00002","journal-title":"Neurologist"},{"issue":"8","key":"4438_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18(8):795\u2013804. https:\/\/doi.org\/10.1016\/S1474-4422(19)30185-1","journal-title":"Lancet Neurol"},{"issue":"6","key":"4438_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40263-019-00630-6","volume":"33","author":"KA Haanes","year":"2019","unstructured":"Haanes KA, Edvinsson L (2019) Pathophysiological mechanisms in migraine and the identification of new therapeutic targets. CNS Drugs 33(6):525\u2013537. https:\/\/doi.org\/10.1007\/s40263-019-00630-6","journal-title":"CNS Drugs"},{"issue":"17","key":"4438_CR6","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","volume":"35","author":"R Burstein","year":"2015","unstructured":"Burstein R, Noseda R, Borsook D (2015) Migraine: multiple processes, complex pathophysiology. J Neurosci 35(17):6619\u20136629. https:\/\/doi.org\/10.1523\/JNEUROSCI.0373-15.2015","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"4438_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","volume":"58","author":"DW Dodick","year":"2018","unstructured":"Dodick DW (2018) A phase-by-phase review of migraine pathophysiology. Headache 58(Suppl 1):4\u201316. https:\/\/doi.org\/10.1111\/head.13300","journal-title":"Headache"},{"key":"4438_CR8","doi-asserted-by":"crossref","unstructured":"Borsook D, May A, Goadsby P, Hargreaves R (2012) The migraine brain. Oxford UP, New York. ISBN-10: 019975456X","DOI":"10.1093\/acprof:oso\/9780199754564.001.0001"},{"issue":"5","key":"4438_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/life11050415","volume":"11","author":"O Grech","year":"2021","unstructured":"Grech O, Mollan SP, Wakerley BR, Fulton D, Lavery GG, Sinclair AJ (2021) The role of metabolism in migraine pathophysiology and susceptibility. Life 11(5):415. https:\/\/doi.org\/10.3390\/life11050415","journal-title":"Life"},{"issue":"11","key":"4438_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41582-019-0255-4","volume":"15","author":"EC Gross","year":"2019","unstructured":"Gross EC, Lisicki M, Fischer D, S\u00e1ndor PS, Schoenen J (2019) The metabolic face of migraine\u2014from pathophysiology to treatment. Nat Rev Neurol 15(11):627\u2013643. https:\/\/doi.org\/10.1038\/s41582-019-0255-4","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"4438_CR11","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1212\/wnl.39.9.1239","volume":"39","author":"MD Ferrari","year":"1989","unstructured":"Ferrari MD, Odink J, Tapparelli C, Van Kempen GM, Pennings EJ, Bruyn GW (1989) Serotonin metabolism in migraine. Neurology 39(9):1239\u20131242. https:\/\/doi.org\/10.1212\/wnl.39.9.1239","journal-title":"Neurology"},{"issue":"11","key":"4438_CR12","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s10072-019-03984-3","volume":"40","author":"S Razeghi Jahromi","year":"2019","unstructured":"Razeghi Jahromi S, Togha M, Ghorbani Z, Hekmatdoost A, Khorsha F, Rafiee P, Shirani P, Nourmohammadi M, Ansari H (2019) The association between dietary tryptophan intake and migraine. Neurol Sci 40(11):2349\u20132355. https:\/\/doi.org\/10.1007\/s10072-019-03984-3","journal-title":"Neurol Sci"},{"issue":"10","key":"4438_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1468-2982.2006.01212.x","volume":"26","author":"PD Drummond","year":"2006","unstructured":"Drummond PD (2006) Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia 26(10):1225\u20131233. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01212.x","journal-title":"Cephalalgia"},{"issue":"6","key":"4438_CR14","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/ijms22062973","volume":"22","author":"W Roth","year":"2021","unstructured":"Roth W, Zadeh K, Vekariya R, Ge Y, Mohamadzadeh M (2021) Tryptophan metabolism and gut-brain homeostasis. Int J Mol Sci 22(6):2973. https:\/\/doi.org\/10.3390\/ijms22062973","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4438_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/14737175.2015.1049999","volume":"15","author":"I Davis","year":"2015","unstructured":"Davis I, Liu A (2015) What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics? Expert Rev Neurother 15(7):719\u2013721. https:\/\/doi.org\/10.1586\/14737175.2015.1049999","journal-title":"Expert Rev Neurother"},{"key":"4438_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10194-016-0638-5","volume":"17","author":"M Curto","year":"2016","unstructured":"Curto M, Lionetto L, Negro A, Capi M, Fazio F, Giamberardino MA, Simmaco M, Nicoletti F, Martelletti P (2016) Altered kynurenine pathway metabolites in serum of chronic migraine patients. J Headache Pain 17:47. https:\/\/doi.org\/10.1186\/s10194-016-0638-5","journal-title":"J Headache Pain"},{"issue":"4","key":"4438_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/phrs.1998.0362","volume":"38","author":"SO Heyliger","year":"1998","unstructured":"Heyliger SO, Goodman CB, Ngong JM, Soliman KF (1998) The analgesic effects of tryptophan and its metabolites in the rat. Pharmacol Res 38(4):243\u2013250. https:\/\/doi.org\/10.1006\/phrs.1998.0362","journal-title":"Pharmacol Res"},{"issue":"4","key":"4438_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","volume":"72","author":"TW Stone","year":"1981","unstructured":"Stone TW, Perkins MN (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72(4):411\u2013412. https:\/\/doi.org\/10.1016\/0014-2999(81)90587-2","journal-title":"Eur J Pharmacol"},{"key":"4438_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nicl.2018.01.016","volume":"18","author":"M Deen","year":"2018","unstructured":"Deen M, Hansen HD, Hougaard A, N\u00f8rgaard M, Eiberg H, Lehel S, Ashina M, Knudsen GM (2018) High brain serotonin levels in migraine between attacks: a 5-HT4 receptor binding PET study. Neuroimage Clin 18:97\u2013102. https:\/\/doi.org\/10.1016\/j.nicl.2018.01.016","journal-title":"Neuroimage Clin"},{"issue":"4","key":"4438_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/0333102418793642","volume":"39","author":"M Deen","year":"2019","unstructured":"Deen M, Hougaard A, Hansen HD, Svarer C, Eiberg H, Lehel S, Knudsen GM, Ashina M (2019) Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding. Cephalalgia 39(4):526\u2013532. https:\/\/doi.org\/10.1177\/0333102418793642","journal-title":"Cephalalgia"},{"issue":"3","key":"4438_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3164\/jcbn.33.95","volume":"33","author":"TAM Aziz","year":"2003","unstructured":"Aziz TAM, Fouad HH, Rashed LA, Fathy S (2003) Serotonin and its metabolite; 5-hydroxyindoleacetic acid in neurophysiology of headache. J Clin Biochem Nutr 33(3):95\u2013100. https:\/\/doi.org\/10.3164\/jcbn.33.95","journal-title":"J Clin Biochem Nutr"},{"issue":"2","key":"4438_CR22","first-page":"77","volume":"23","author":"O Bruera","year":"2008","unstructured":"Bruera O, Sances G, Leston J, Levin G, Cristina S, Medina C, Barontini M, Nappi G, Figuerola MA (2008) Plasma melatonin pattern in chronic and episodic headaches: evaluation during sleep and waking. Funct Neurol 23(2):77\u201381","journal-title":"Funct Neurol"},{"issue":"Suppl 1","key":"4438_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10072-019-03837-z","volume":"40","author":"L Ferini-Strambi","year":"2019","unstructured":"Ferini-Strambi L, Galbiati A, Combi R (2019) Sleep disorder-related headaches. Neurol Sci 40(Suppl 1):107\u2013113. https:\/\/doi.org\/10.1007\/s10072-019-03837-z","journal-title":"Neurol Sci"},{"issue":"15","key":"4438_CR24","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/archinte.1997.00440360117014","volume":"157","author":"T Paiva","year":"1997","unstructured":"Paiva T, Farinha A, Martins A, Batista A, Guilleminault C (1997) Chronic headaches and sleep disorders. Arch Intern Med 157(15):1701\u20131705","journal-title":"Arch Intern Med"},{"issue":"12","key":"4438_CR25","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s10072-014-1867-5","volume":"35","author":"G D'Andrea","year":"2014","unstructured":"D\u2019Andrea G, D\u2019Amico D, Bussone G, Bolner A, Aguggia M, Saracco MG, Galloni E, De Riva V, D\u2019Arrigo A, Colavito D, Leon A, Perini F (2014) Tryptamine levels are low in plasma of chronic migraine and chronic tension-type headache. Neurol Sci 35(12):1941\u20131945. https:\/\/doi.org\/10.1007\/s10072-014-1867-5","journal-title":"Neurol Sci"},{"issue":"15","key":"4438_CR26","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/0006-2952(89)90083-x","volume":"38","author":"P Russi","year":"1989","unstructured":"Russi P, Carl\u00e0 V, Moroni F (1989) Indolpyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory amino acid receptors in vivo? Biochem Pharmacol 38(15):2405\u20132409. https:\/\/doi.org\/10.1016\/0006-2952(89)90083-x","journal-title":"Biochem Pharmacol"},{"key":"4438_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/978-1-4684-5952-4_57","volume":"294","author":"V Politi","year":"1991","unstructured":"Politi V, Lavaggi MV, Di Stazio G, Margonelli A (1991) Indole-3-pyruvic acid as a direct precursor of kynurenic acid. Adv Exp Med Biol 294:515\u2013518. https:\/\/doi.org\/10.1007\/978-1-4684-5952-4_57","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"4438_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s10194-021-01239-1","volume":"22","author":"B Tuka","year":"2021","unstructured":"Tuka B, Ny\u00e1ri A, Cseh EK, K\u00f6rt\u00e9si T, Ver\u00e9b D, T\u00f6m\u00f6si F, Kecskem\u00e9ti G, Jan\u00e1ky T, Tajti J, V\u00e9csei L (2021) Clinical relevance of depressed kynurenine pathway in episodic migraine patients: potential prognostic markers in the peripheral plasma during the interictal period. J Headache Pain 22(1):60. https:\/\/doi.org\/10.1186\/s10194-021-01239-1","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"4438_CR29","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1007\/BF01642905","volume":"238","author":"PP Humphrey","year":"1991","unstructured":"Humphrey PP (1991) 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol 238(Suppl 1):S38-44. https:\/\/doi.org\/10.1007\/BF01642905","journal-title":"J Neurol"},{"issue":"10","key":"4438_CR30","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","volume":"87","author":"AL Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves AL, Martini Ferreira A, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MF (2016) Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry 87(10):1127\u20131132. https:\/\/doi.org\/10.1136\/jnnp-2016-313458","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"4438_CR31","doi-asserted-by":"publisher","first-page":"e14099","DOI":"10.1097\/MD.0000000000014099","volume":"98","author":"R Long","year":"2019","unstructured":"Long R, Zhu Y, Zhou S (2019) Therapeutic role of melatonin in migraine prophylaxis: a systematic review. Medicine 98(3):e14099. https:\/\/doi.org\/10.1097\/MD.0000000000014099","journal-title":"Medicine"},{"issue":"1","key":"4438_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5603\/PJNNS.a2021.0002","volume":"55","author":"D Zielonka","year":"2021","unstructured":"Zielonka D (2021) Melatonin secretion in migraine patients: the current state of knowledge. Neurol Neurochir Pol 55(1):5\u20137. https:\/\/doi.org\/10.5603\/PJNNS.a2021.0002","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"4438_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5603\/PJNNS.a2020.0095","volume":"55","author":"A Zdu\u0144ska","year":"2021","unstructured":"Zdu\u0144ska A, Cegielska J, Zdu\u0144ski S, Bia\u0142obrzewski M, Kochanowski J (2021) Variability in melatonin concentration in blood serum of patients with episodic migraine: a pilot study. Neurol Neurochir Pol 55(1):81\u201390. https:\/\/doi.org\/10.5603\/PJNNS.a2020.0095","journal-title":"Neurol Neurochir Pol"},{"issue":"1","key":"4438_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13760-016-0723-1","volume":"117","author":"HH Kozak","year":"2017","unstructured":"Kozak HH, Boysan M, Uca AU, Ayd\u0131n A, K\u0131l\u0131n\u00e7 \u0130, Gen\u00e7 E, Alta\u015f M, G\u00fcng\u00f6r DC, Turgut K, \u00d6zer N (2017) Sleep quality, morningness-eveningness preference, mood profile, and levels of serum melatonin in migraine patients: a case-control study. Acta Neurol Belg 117(1):111\u2013119. https:\/\/doi.org\/10.1007\/s13760-016-0723-1","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"4438_CR35","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1526-4610.1989.hed22904242.x","volume":"29","author":"B Claustrat","year":"1989","unstructured":"Claustrat B, Loisy C, Brun J, Beorchia S, Arnaud JL, Chazot G (1989) Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache 29(4):242\u2013245. https:\/\/doi.org\/10.1111\/j.1526-4610.1989.hed22904242.x","journal-title":"Headache"},{"issue":"12","key":"4438_CR36","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67(12):2154\u20132158. https:\/\/doi.org\/10.1212\/01.wnl.0000233888.18228.19","journal-title":"Neurology"},{"issue":"7","key":"4438_CR37","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s00415-020-09726-2","volume":"268","author":"LM Cupini","year":"2021","unstructured":"Cupini LM, Corbelli I, Sarchelli P (2021) Menstrual migraine: what it is and does it matter? J Neurol 268(7):2355\u20132363. https:\/\/doi.org\/10.1007\/s00415-020-09726-2","journal-title":"J Neurol"},{"issue":"3","key":"4438_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1468-2982.1994.014003205.x","volume":"14","author":"G Murialdo","year":"1994","unstructured":"Murialdo G, Fonzi S, Costelli P, Solinas GP, Parodi C, Marabini S, Fanciullacci M, Polleri A (1994) Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia 14(3):205\u2013209. https:\/\/doi.org\/10.1046\/j.1468-2982.1994.014003205.x","journal-title":"Cephalalgia"},{"issue":"3","key":"4438_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1210\/jcem-53-3-645","volume":"53","author":"U Lang","year":"1981","unstructured":"Lang U, Kornemark M, Aubert ML, Paunier L, Sizonenko PC (1981) Radioimmunological determination of urinary melatonin in humans: correlation with plasma levels and typical 24-hour rhythmicity. J Clin Endocrinol Metab 53(3):645\u2013650. https:\/\/doi.org\/10.1210\/jcem-53-3-645","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4438_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s10194-016-0620-2","volume":"17","author":"M Curto","year":"2016","unstructured":"Curto M, Lionetto L, Negro A, Capi M, Perugino F, Fazio F, Giamberardino MA, Simmaco M, Nicoletti F, Martelletti P (2016) Altered serum levels of kynurenine metabolites in patients affected by cluster headache. J Headache Pain 17(1):27. https:\/\/doi.org\/10.1186\/s10194-016-0620-2","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"4438_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10072-017-2862-4","volume":"38","author":"G D'Andrea","year":"2017","unstructured":"D\u2019Andrea G, Bussone G, Di Fiore P, Perini F, Gucciardi A, Bolner A, Aguggia M, Saracco G, Galloni E, Giordano G, Leon A (2017) Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and \u03b11-agonists. Neurol Sci 38(Suppl 1):37\u201343. https:\/\/doi.org\/10.1007\/s10072-017-2862-4","journal-title":"Neurol Sci"},{"key":"4438_CR42","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/DDDT.S44496","volume":"7","author":"G Ol\u00e1h","year":"2013","unstructured":"Ol\u00e1h G, Her\u00e9di J, Menyh\u00e1rt A, Czinege Z, Nagy D, Fuzik J, Kocsis K, Knapp L, Krucs\u00f3 E, Gell\u00e9rt L, Kis Z, Farkas T, F\u00fcl\u00f6p F, P\u00e1rdutz A, Tajti J, V\u00e9csei L, Toldi J (2013) Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability. Drug Des Devel Ther 7:981\u2013987. https:\/\/doi.org\/10.2147\/DDDT.S44496","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"4438_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.mehy.2008.11.037","volume":"72","author":"R Ye","year":"2009","unstructured":"Ye R, Kong X, Han J, Zhao G (2009) N-methyl-D-aspartate receptor antagonists for migraine: a potential therapeutic approach. Med Hypotheses 72(5):603\u2013605. https:\/\/doi.org\/10.1016\/j.mehy.2008.11.037","journal-title":"Med Hypotheses"},{"issue":"4","key":"4438_CR44","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.neuroscience.2010.05.052","volume":"169","author":"A Konradsson-Geuken","year":"2010","unstructured":"Konradsson-Geuken A, Wu HQ, Gash CR, Alexander KS, Campbell A, Sozeri Y, Pellicciari R, Schwarcz R, Bruno JP (2010) Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry. Neuroscience 169(4):1848\u20131859. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.05.052","journal-title":"Neuroscience"},{"issue":"2","key":"4438_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.expneurol.2012.05.002","volume":"236","author":"V Chauvel","year":"2012","unstructured":"Chauvel V, Vamos E, Pardutz A, Vecsei L, Schoenen J, Multon S (2012) Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat. Exp Neurol 236(2):207\u2013214. https:\/\/doi.org\/10.1016\/j.expneurol.2012.05.002","journal-title":"Exp Neurol"},{"issue":"6","key":"4438_CR46","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56(6):2007\u20132017. https:\/\/doi.org\/10.1111\/j.1471-4159.1991.tb03460.x","journal-title":"J Neurochem"},{"issue":"2","key":"4438_CR47","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/1570159x14666151113123221","volume":"14","author":"Z Majl\u00e1th","year":"2016","unstructured":"Majl\u00e1th Z, T\u00f6r\u00f6k N, Toldi J, V\u00e9csei L (2016) Memantine and kynurenic acid: current neuropharmacological aspects. Curr Neuropharmacol 14(2):200\u2013209. https:\/\/doi.org\/10.2174\/1570159x14666151113123221","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"4438_CR48","first-page":"309","volume":"45","author":"TW Stone","year":"1993","unstructured":"Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45(3):309\u2013379","journal-title":"Pharmacol Rev"},{"issue":"19","key":"4438_CR49","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21(19):7463\u20137473. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-19-07463.2001","journal-title":"J Neurosci"},{"issue":"8","key":"4438_CR50","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1038\/npp.2010.39","volume":"35","author":"MC Potter","year":"2010","unstructured":"Potter MC, Elmer GI, Bergeron R, Albuquerque EX, Guidetti P, Wu HQ, Schwarcz R (2010) Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology 35(8):1734\u20131742. https:\/\/doi.org\/10.1038\/npp.2010.39","journal-title":"Neuropsychopharmacology"},{"issue":"31","key":"4438_CR51","doi-asserted-by":"publisher","first-page":"22021","DOI":"10.1074\/jbc.M603503200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281(31):22021\u201322008. https:\/\/doi.org\/10.1074\/jbc.M603503200","journal-title":"J Biol Chem"},{"issue":"1","key":"4438_CR52","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1124\/jpet.107.127266","volume":"324","author":"J Guo","year":"2008","unstructured":"Guo J, Williams DJ, Puhl HL 3rd, Ikeda SR (2008) Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons. J Pharmacol Exp Ther 324(1):342\u2013351. https:\/\/doi.org\/10.1124\/jpet.107.127266","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"4438_CR53","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/s0896-6273(00)81249-0","volume":"18","author":"B Laube","year":"1997","unstructured":"Laube B, Hirai H, Sturgess M, Betz H, Kuhse J (1997) Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron 18(3):493\u2013503. https:\/\/doi.org\/10.1016\/s0896-6273(00)81249-0","journal-title":"Neuron"},{"issue":"6220","key":"4438_CR54","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pont\u00e9n F (2015) Tissue-based map of the human proteome. Science 347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419","journal-title":"Science"},{"issue":"2","key":"4438_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","volume":"15","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Charles A (2018) Glutamate and its receptors as therapeutic targets for migraine. Neurotherapeutics 15(2):361\u2013370. https:\/\/doi.org\/10.1007\/s13311-018-0616-5","journal-title":"Neurotherapeutics"},{"issue":"2","key":"4438_CR56","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3390\/ijms13022219","volume":"13","author":"M Pohanka","year":"2012","unstructured":"Pohanka M (2012) Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology. Int J Mol Sci 13(2):2219\u20132238. https:\/\/doi.org\/10.3390\/ijms13022219","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4438_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s0006-8993(98)00862-2","volume":"809","author":"L Liu","year":"1998","unstructured":"Liu L, Chang GQ, Jiao YQ, Simon SA (1998) Neuronal nicotinic acetylcholine receptors in rat trigeminal ganglia. Brain Res 809(2):238\u2013245. https:\/\/doi.org\/10.1016\/s0006-8993(98)00862-2","journal-title":"Brain Res"},{"issue":"11","key":"4438_CR58","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1046\/j.0953-816x.2001.01592.x","volume":"13","author":"R Carpenedo","year":"2001","unstructured":"Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, Moroni F (2001) Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci 13(11):2141\u20132147. https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01592.x","journal-title":"Eur J Neurosci"},{"issue":"3","key":"4438_CR59","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s002210000351","volume":"132","author":"E Carstens","year":"2000","unstructured":"Carstens E, Simons CT, Dessirier JM, Carstens MI, Jinks SL (2000) Role of neuronal nicotinic-acetylcholine receptors in the activation of neurons in trigeminal subnucleus caudalis by nicotine delivered to the oral mucosa. Exp Brain Res 132(3):375\u2013383. https:\/\/doi.org\/10.1007\/s002210000351","journal-title":"Exp Brain Res"},{"issue":"1\u20133","key":"4438_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neulet.2003.08.064","volume":"361","author":"S Papadopolou","year":"2004","unstructured":"Papadopolou S, Hartmann P, Lips KS, Kummer W, Haberberger RV (2004) Nicotinic receptor mediated stimulation of NO-generation in neurons of rat thoracic dorsal root ganglia. Neurosci Lett 361(1\u20133):32\u201335. https:\/\/doi.org\/10.1016\/j.neulet.2003.08.064","journal-title":"Neurosci Lett"},{"issue":"7","key":"4438_CR61","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00702-013-1146-2","volume":"121","author":"A Fejes-Szab\u00f3","year":"2014","unstructured":"Fejes-Szab\u00f3 A, Boh\u00e1r Z, V\u00e1mos E, Nagy-Gr\u00f3cz G, Tar L, Veres G, Z\u00e1dori D, Szentirmai M, Tajti J, Szatm\u00e1ri I, F\u00fcl\u00f6p F, Toldi J, P\u00e1rdutz \u00c1, V\u00e9csei L (2014) Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex. J Neural Transm 121(7):725\u2013738. https:\/\/doi.org\/10.1007\/s00702-013-1146-2","journal-title":"J Neural Transm"},{"issue":"7\u20138","key":"4438_CR62","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.neuropharm.2010.11.014","volume":"60","author":"C Cosi","year":"2011","unstructured":"Cosi C, Mannaioni G, Cozzi A, Carl\u00e0 V, Sili M, Cavone L, Maratea D, Moroni F (2011) G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: studies on the antinociceptive effects of kynurenic acid and zaprinast. Neuropharmacology 60(7\u20138):1227\u20131231. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.11.014","journal-title":"Neuropharmacology"},{"issue":"Pt B","key":"4438_CR63","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.neuropharm.2015.07.035","volume":"113","author":"AE Mackenzie","year":"2017","unstructured":"Mackenzie AE, Milligan G (2017) The emerging pharmacology and function of GPR35 in the nervous system. Neuropharmacology 113(Pt B):661\u2013671. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.07.035","journal-title":"Neuropharmacology"},{"issue":"7","key":"4438_CR64","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.pain.2012.04.015","volume":"153","author":"J Lee","year":"2012","unstructured":"Lee J, Saloman JL, Weiland G, Auh QS, Chung MK, Ro JY (2012) Functional interactions between NMDA receptors and TRPV1 in trigeminal sensory neurons mediate mechanical hyperalgesia in the rat masseter muscle. Pain 153(7):1514\u20131524. https:\/\/doi.org\/10.1016\/j.pain.2012.04.015","journal-title":"Pain"},{"issue":"4","key":"4438_CR65","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00429-014-0762-4","volume":"220","author":"I Shelukhina","year":"2015","unstructured":"Shelukhina I, Paddenberg R, Kummer W, Tsetlin V (2015) Functional expression and axonal transport of \u03b17 nAChRs by peptidergic nociceptors of rat dorsal root ganglion. Brain Struct Funct 220(4):1885\u20131899. https:\/\/doi.org\/10.1007\/s00429-014-0762-4","journal-title":"Brain Struct Funct"},{"issue":"Pt 5","key":"4438_CR66","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A et al (1992) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 115(Pt 5):1249\u20131273. https:\/\/doi.org\/10.1093\/brain\/115.5.1249","journal-title":"Brain"},{"key":"4438_CR67","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-1-4615-0135-0_46","volume":"527","author":"CM Forrest","year":"2003","unstructured":"Forrest CM, Gould SR, Darlington LG, Stone TW (2003) Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol 527:395\u2013400. https:\/\/doi.org\/10.1007\/978-1-4615-0135-0_46","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"4438_CR68","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrd870","volume":"1","author":"TW Stone","year":"2002","unstructured":"Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 1(8):609\u2013620. https:\/\/doi.org\/10.1038\/nrd870","journal-title":"Nat Rev Drug Discov"},{"key":"4438_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4137\/ijtr.s2469","volume":"2","author":"RS Grant","year":"2009","unstructured":"Grant RS, Coggan SE, Smythe GA (2009) The physiological action of picolinic Acid in the human brain. Int J Tryptophan Res 2:71\u201379. https:\/\/doi.org\/10.4137\/ijtr.s2469","journal-title":"Int J Tryptophan Res"},{"issue":"3","key":"4438_CR70","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/0306-4522(94)90438-3","volume":"61","author":"RJ Beninger","year":"1994","unstructured":"Beninger RJ, Colton AM, Ingles JL, Jhamandas K, Boegman RJ (1994) Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry. Neuroscience 61(3):603\u2013612. https:\/\/doi.org\/10.1016\/0306-4522(94)90438-3","journal-title":"Neuroscience"},{"issue":"2","key":"4438_CR71","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2010","unstructured":"Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ (2010) Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease. Prog Neurobiol 90(2):230\u2013245. https:\/\/doi.org\/10.1016\/j.pneurobio.2009.04.005","journal-title":"Prog Neurobiol"},{"issue":"7","key":"4438_CR72","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1515\/CCLM.2003.129","volume":"41","author":"TW Stone","year":"2003","unstructured":"Stone TW, Mackay GM, Forrest CM, Clark CJ, Darlington LG (2003) Tryptophan metabolites and brain disorders. Clin Chem Lab Med 41(7):852\u2013859. https:\/\/doi.org\/10.1515\/CCLM.2003.129","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"4438_CR73","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","volume":"15","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson L, Haanes KA, Warfvinge K (2019) Does inflammation have a role in migraine? Nat Rev Neurol 15(8):483\u2013490. https:\/\/doi.org\/10.1038\/s41582-019-0216-y","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"4438_CR74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/0972-2327.182302","volume":"19","author":"R Malhotra","year":"2016","unstructured":"Malhotra R (2016) Understanding migraine: potential role of neurogenic inflammation. Ann Indian Acad Neurol 19(2):175\u2013182. https:\/\/doi.org\/10.4103\/0972-2327.182302","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"4438_CR75","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10194-021-01271-1","volume":"22","author":"O Kursun","year":"2021","unstructured":"Kursun O, Yemisci M, van den Maagdenberg AMJM, Karatas H (2021) Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain 22(1):55. https:\/\/doi.org\/10.1186\/s10194-021-01271-1","journal-title":"J Headache Pain"},{"issue":"3","key":"4438_CR76","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.ajpath.2011.05.048","volume":"179","author":"D Krause","year":"2011","unstructured":"Krause D, Suh HS, Tarassishin L, Cui QL, Durafourt BA, Choi N, Bauman A, Cosenza-Nashat M, Antel JP, Zhao ML, Lee SC (2011) The tryptophan metabolite 3-hydroxyanthranilic acid plays anti-inflammatory and neuroprotective roles during inflammation: role of hemeoxygenase-1. Am J Pathol 179(3):1360\u20131372. https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.048","journal-title":"Am J Pathol"},{"issue":"5","key":"4438_CR77","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1124\/mol.111.074765","volume":"81","author":"F Fazio","year":"2012","unstructured":"Fazio F, Lionetto L, Molinaro G, Bertrand HO, Acher F, Ngomba RT, Notartomaso S, Curini M, Rosati O, Scarselli P, Di Marco R, Battaglia G, Bruno V, Simmaco M, Pin JP, Nicoletti F, Goudet C (2012) Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors. Mol Pharmacol 81(5):643\u2013656. https:\/\/doi.org\/10.1124\/mol.111.074765","journal-title":"Mol Pharmacol"},{"key":"4438_CR78","doi-asserted-by":"publisher","first-page":"17799","DOI":"10.1038\/srep17799","volume":"5","author":"F Fazio","year":"2015","unstructured":"Fazio F, Lionetto L, Curto M, Iacovelli L, Cavallari M, Zappulla C, Ulivieri M, Napoletano F, Capi M, Corigliano V, Scaccianoce S, Caruso A, Miele J, De Fusco A, Di Menna L, Comparelli A, De Carolis A, Gradini R, Nistic\u00f2 R, De Blasi A, Girardi P, Bruno V, Battaglia G, Nicoletti F, Simmaco M (2015) Xanthurenic acid activates mGlu2\/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia. Sci Rep 5:17799. https:\/\/doi.org\/10.1038\/srep17799","journal-title":"Sci Rep"},{"issue":"Pt B","key":"4438_CR79","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuropharm.2016.06.020","volume":"112","author":"F Fazio","year":"2017","unstructured":"Fazio F, Lionetto L, Curto M, Iacovelli L, Copeland CS, Neale SA, Bruno V, Battaglia G, Salt TE, Nicoletti F (2017) Cinnabarinic acid and xanthurenic acid: two kynurenine metabolites that interact with metabotropic glutamate receptors. Neuropharmacology 112(Pt B):365\u2013372. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.06.020","journal-title":"Neuropharmacology"},{"key":"4438_CR80","doi-asserted-by":"publisher","first-page":"17799","DOI":"10.1038\/srep17799","volume":"5","author":"R Gradini","year":"2015","unstructured":"Gradini R, Nistic\u00f2 R, De Blasi A, Girardi P, Bruno V, Battaglia G, Nicoletti F, Simmaco M (2015) Xanthurenic acid activates mGlu2\/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia. Sci Rep 5:17799. https:\/\/doi.org\/10.1038\/srep17799","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"4438_CR81","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0169-328x(95)00321-i","volume":"37","author":"A Makoff","year":"1996","unstructured":"Makoff A, Lelchuk R, Oxer M, Harrington K, Emson P (1996) Molecular characterization and localization of human metabotropic glutamate receptor type 4. Brain Res Mol Brain Res 37(1\u20132):239\u2013248. https:\/\/doi.org\/10.1016\/0169-328x(95)00321-i","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"4438_CR82","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0169-328x(96)00037-x","volume":"40","author":"A Makoff","year":"1996","unstructured":"Makoff A, Volpe F, Lelchuk R, Harrington K, Emson P (1996) Molecular characterization and localization of human metabotropic glutamate receptor type 3. Brain Res Mol Brain Res 40(1):55\u201363. https:\/\/doi.org\/10.1016\/0169-328x(96)00037-x","journal-title":"Brain Res Mol Brain Res"},{"issue":"11","key":"4438_CR83","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/j.bmcl.2010.04.001","volume":"v20","author":"D Schmidt","year":"2010","unstructured":"Schmidt D, Smenton A, Raghavan S, Shen H, Ding FX, Carballo-Jane E, Luell S, Ciecko T, Holt TG, Wolff M, Taggart A, Wilsie L, Krsmanovic M, Ren N, Blom D, Cheng K, McCann PE, Waters MG, Tata J, Colletti S (2010) Anthranilic acid replacements in a niacin receptor agonist. Bioorg Med Chem Lett v20(11):3426\u20133430. https:\/\/doi.org\/10.1016\/j.bmcl.2010.04.001","journal-title":"Bioorg Med Chem Lett"},{"issue":"18","key":"4438_CR84","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1016\/j.bmcl.2008.08.011","volume":"18","author":"BG Shearer","year":"2008","unstructured":"Shearer BG, Patel HS, Billin AN, Way JM, Winegar DA, Lambert MH, Xu RX, Leesnitzer LM, Merrihew RV, Huet S, Willson TM (2008) Discovery of a novel class of PPARdelta partial agonists. Bioorg Med Chem Lett 18(18):5018\u20135022. https:\/\/doi.org\/10.1016\/j.bmcl.2008.08.011","journal-title":"Bioorg Med Chem Lett"},{"key":"4438_CR85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1475-2891-4-3","volume":"4","author":"J Prousky","year":"2005","unstructured":"Prousky J, Seely D (2005) The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature. Nutr J 4:3. https:\/\/doi.org\/10.1186\/1475-2891-4-3","journal-title":"Nutr J"},{"issue":"2","key":"4438_CR86","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1124\/pr.110.003301","volume":"63","author":"S Offermanns","year":"2011","unstructured":"Offermanns S, Colletti SL, Lovenberg TW, Semple G, Wise A, IJzerman AP (2011) International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B). Pharmacol Rev 63(2):269\u2013290. https:\/\/doi.org\/10.1124\/pr.110.003301","journal-title":"Pharmacol Rev"},{"issue":"11","key":"4438_CR87","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1074\/jbc.M210695200","volume":"278","author":"A Wise","year":"2003","unstructured":"Wise A, Foord SM, Fraser NJ, Barnes AA, Elshourbagy N, Eilert M, Ignar DM, Murdock PR, Steplewski K, Green A, Brown AJ, Dowell SJ, Szekeres PG, Hassall DG, Marshall FH, Wilson S, Pike NB (2003) Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 278(11):9869\u20139874. https:\/\/doi.org\/10.1074\/jbc.M210695200","journal-title":"J Biol Chem"},{"key":"4438_CR88","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/ncomms4944","volume":"5","author":"M Rahman","year":"2014","unstructured":"Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, M\u00fcller-Fielitz H, Pokorn\u00e1 B, Vollbrandt T, St\u00f6lting I, Nadrowitz R, Okun JG, Offermanns S, Schwaninger M (2014) The \u03b2-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat Commun 5:3944. https:\/\/doi.org\/10.1038\/ncomms4944","journal-title":"Nat Commun"},{"key":"4438_CR89","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/wmts.50","volume":"1","author":"J Masson","year":"2012","unstructured":"Masson J, Emerit MB, Hamon M, Darmon M (2012) Serotonergic signaling: multiple effectors and pleiotropic effects. WIREs Membr Transp Signal 1:685\u2013713. https:\/\/doi.org\/10.1002\/wmts.50","journal-title":"WIREs Membr Transp Signal"},{"issue":"2","key":"4438_CR90","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00441-006-0286-1","volume":"326","author":"J Bockaert","year":"2006","unstructured":"Bockaert J, Claeysen S, B\u00e9camel C, Dumuis A, Marin P (2006) Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res 326(2):553\u2013572. https:\/\/doi.org\/10.1007\/s00441-006-0286-1","journal-title":"Cell Tissue Res"},{"issue":"2\u20133","key":"4438_CR91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/s0163-7258(01)00169-3","volume":"92","author":"JR Raymond","year":"2001","unstructured":"Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92(2\u20133):179\u2013212. https:\/\/doi.org\/10.1016\/s0163-7258(01)00169-3","journal-title":"Pharmacol Ther"},{"key":"4438_CR92","doi-asserted-by":"publisher","first-page":"104949","DOI":"10.1016\/j.phrs.2020.104949","volume":"159","author":"QQ Liu","year":"2020","unstructured":"Liu QQ, Yao XX, Gao SH, Li R, Li BJ, Yang W, Cui RJ (2020) Role of 5-HT receptors in neuropathic pain: potential therapeutic implications. Pharmacol Res 159:104949. https:\/\/doi.org\/10.1016\/j.phrs.2020.104949","journal-title":"Pharmacol Res"},{"issue":"10","key":"4438_CR93","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/14656566.2021.1910235","volume":"22","author":"M Tanaka","year":"2021","unstructured":"Tanaka M, T\u00f6r\u00f6k N, V\u00e9csei L (2021) Are 5-HT1 receptor agonists effective anti-migraine drugs? Expert Opin Pharmacother 22(10):1221\u20131225. https:\/\/doi.org\/10.1080\/14656566.2021.1910235","journal-title":"Expert Opin Pharmacother"},{"key":"4438_CR94","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/JPR.S132833","volume":"11","author":"A Negro","year":"2018","unstructured":"Negro A, Koverech A, Martelletti P (2018) Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential. J Pain Res 11:515\u2013526. https:\/\/doi.org\/10.2147\/JPR.S132833","journal-title":"J Pain Res"},{"issue":"1","key":"4438_CR95","doi-asserted-by":"publisher","first-page":"15","DOI":"10.33549\/physiolres.931903","volume":"60","author":"M Pytliak","year":"2011","unstructured":"Pytliak M, Vargov\u00e1 V, Mech\u00edrov\u00e1 V, Fels\u00f6ci M (2011) Serotonin receptors\u2014from molecular biology to clinical applications. Physiol Res 60(1):15\u201325. https:\/\/doi.org\/10.33549\/physiolres.931903","journal-title":"Physiol Res"},{"key":"4438_CR96","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fncel.2016.00272","volume":"10","author":"PS Rojas","year":"2016","unstructured":"Rojas PS, Fiedler JL (2016) What do we really know about 5-HT1A receptor signaling in neuronal cells? Front Cell Neurosci 10:272. https:\/\/doi.org\/10.3389\/fncel.2016.00272","journal-title":"Front Cell Neurosci"},{"issue":"Pt 1","key":"4438_CR97","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1113\/jphysiol.2003.048041","volume":"552","author":"Y Ootsuka","year":"2003","unstructured":"Ootsuka Y, Blessing WW (2003) 5-Hydroxytryptamine 1A receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits. J Physiol 552(Pt 1):303\u2013314. https:\/\/doi.org\/10.1113\/jphysiol.2003.048041","journal-title":"J Physiol"},{"key":"4438_CR98","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.brainres.2005.12.031","volume":"1073\u20131074","author":"Y Ootsuka","year":"2006","unstructured":"Ootsuka Y, Blessing WW (2006) Activation of 5-HT1A receptors in rostral medullary raph\u00e9 inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits. Brain Res 1073\u20131074:252\u2013261. https:\/\/doi.org\/10.1016\/j.brainres.2005.12.031","journal-title":"Brain Res"},{"issue":"7","key":"4438_CR99","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/archneur.59.7.1084","volume":"59","author":"SJ Tepper","year":"2002","unstructured":"Tepper SJ, Rapoport AM, Sheftell FD (2002) Mechanisms of action of the 5-HT1B\/1D receptor agonists. Arch Neurol 59(7):1084\u20131088. https:\/\/doi.org\/10.1001\/archneur.59.7.1084","journal-title":"Arch Neurol"},{"issue":"10","key":"4438_CR100","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1177\/0333102410370873","volume":"30","author":"DL Nelson","year":"2010","unstructured":"Nelson DL, Phebus LA, Johnson KW, Wainscott DB, Cohen ML, Calligaro DO, Xu YC (2010) Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan. Cephalalgia 30(10):1159\u20131169. https:\/\/doi.org\/10.1177\/0333102410370873","journal-title":"Cephalalgia"},{"key":"4438_CR101","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.2147\/JPR.S152216","volume":"11","author":"JC Oswald","year":"2018","unstructured":"Oswald JC, Schuster NM (2018) Lasmiditan for the treatment of acute migraine: a review and potential role in clinical practice. J Pain Res 11:2221\u20132227. https:\/\/doi.org\/10.2147\/JPR.S152216","journal-title":"J Pain Res"},{"key":"4438_CR102","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1134\/S1068162019020146","volume":"45","author":"AA Spasov","year":"2019","unstructured":"Spasov AA, Yakovlev DS, Brigadirova AA, Maltsev DV, Agatsarskaya YV (2019) Novel approaches to the development of antimigraine drugs: a focus on 5-HT2A receptor antagonists. Russ J Bioorg Chem 45:76\u201388. https:\/\/doi.org\/10.1134\/S1068162019020146","journal-title":"Russ J Bioorg Chem"},{"issue":"1\u20132","key":"4438_CR103","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00210-007-0179-1","volume":"376","author":"CM Villal\u00f3n","year":"2007","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D (2007) Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors\/mechanisms involved and therapeutic implications. Naunyn Schmiedebergs Arch Pharmacol 376(1\u20132):45\u201363. https:\/\/doi.org\/10.1007\/s00210-007-0179-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"4438_CR104","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1111\/j.1476-5381.2011.01706.x","volume":"165","author":"MA Anwar","year":"2012","unstructured":"Anwar MA, Ford WR, Broadley KJ, Herbert AA (2012) Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and \u03b2-phenylethylamine. Br J Pharmacol 165(7):2191\u20132202. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01706.x","journal-title":"Br J Pharmacol"},{"issue":"7","key":"4438_CR105","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1046\/j.1526-4610.2002.02142.x","volume":"42","author":"A Srikiatkhachorn","year":"2002","unstructured":"Srikiatkhachorn A, Suwattanasophon C, Ruangpattanatawee U, Phansuwan-Pujito P (2002) Wolff Award. 5 -HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks. Headache 42(7):566\u2013574. https:\/\/doi.org\/10.1046\/j.1526-4610.2002.02142.x","journal-title":"Headache"},{"issue":"1","key":"4438_CR106","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1248\/bpb.b15-00735","volume":"39","author":"K Naito","year":"2016","unstructured":"Naito K, Tanaka C, Mitsuhashi M, Moteki H, Kimura M, Natsume H, Ogihara M (2016) Signal transduction mechanism for serotonin 5-HT2B receptor-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. Biol Pharm Bull 39(1):121\u2013129. https:\/\/doi.org\/10.1248\/bpb.b15-00735","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"4438_CR107","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0014-5793(94)80590-3","volume":"342","author":"K Schmuck","year":"1994","unstructured":"Schmuck K, Ullmer C, Engels P, L\u00fcbbert H (1994) Cloning and functional characterization of the human 5-HT2B serotonin receptor. FEBS Lett 342(1):85\u201390. https:\/\/doi.org\/10.1016\/0014-5793(94)80590-3","journal-title":"FEBS Lett"},{"issue":"6132","key":"4438_CR108","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1126\/science.1232808","volume":"340","author":"D Wacker","year":"2013","unstructured":"Wacker D, Wang C, Katritch V, Han GW, Huang XP, Vardy E, McCorvy JD, Jiang Y, Chu M, Siu FY, Liu W, Xu HE, Cherezov V, Roth BL, Stevens RC (2013) Structural features for functional selectivity at serotonin receptors. Science 340(6132):615\u2013619. https:\/\/doi.org\/10.1126\/science.1232808","journal-title":"Science"},{"issue":"13","key":"4438_CR109","doi-asserted-by":"publisher","first-page":"9324","DOI":"10.1074\/jbc.275.13.9324","volume":"275","author":"P Manivet","year":"2000","unstructured":"Manivet P, Mouillet-Richard S, Callebert J, Nebigil CG, Maroteaux L, Hosoda S, Kellermann O, Launay JM (2000) PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor. J Biol Chem 275(13):9324\u20139331. https:\/\/doi.org\/10.1074\/jbc.275.13.9324","journal-title":"J Biol Chem"},{"issue":"1","key":"4438_CR110","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1471-4159.1995.64010199.x","volume":"64","author":"MJ Kaufman","year":"1995","unstructured":"Kaufman MJ, Hartig PR, Hoffman BJ (1995) Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus. J Neurochem 64(1):199\u2013205. https:\/\/doi.org\/10.1046\/j.1471-4159.1995.64010199.x","journal-title":"J Neurochem"},{"issue":"1","key":"4438_CR111","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neuropharm.2008.08.003","volume":"56","author":"NM Barnes","year":"2009","unstructured":"Barnes NM, Hales TG, Lummis SC, Peters JA (2009) The 5-HT3 receptor\u2013the relationship between structure and function. Neuropharmacology 56(1):273\u2013284. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.08.003","journal-title":"Neuropharmacology"},{"issue":"5030","key":"4438_CR112","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1126\/science.1718042","volume":"254","author":"AV Maricq","year":"1991","unstructured":"Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254(5030):432\u2013437. https:\/\/doi.org\/10.1126\/science.1718042","journal-title":"Science"},{"issue":"48","key":"4438_CR113","doi-asserted-by":"publisher","first-page":"40239","DOI":"10.1074\/jbc.R112.406496","volume":"287","author":"SC Lummis","year":"2012","unstructured":"Lummis SC (2012) 5-HT(3) receptors. J Biol Chem 287(48):40239\u201340245. https:\/\/doi.org\/10.1074\/jbc.R112.406496","journal-title":"J Biol Chem"},{"issue":"6227","key":"4438_CR114","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/339706a0","volume":"339","author":"V Derkach","year":"1989","unstructured":"Derkach V, Surprenant A, North RA (1989) 5-HT3 receptors are membrane ion channels. Nature 339(6227):706\u2013709. https:\/\/doi.org\/10.1038\/339706a0","journal-title":"Nature"},{"issue":"6","key":"4438_CR115","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1085\/jgp.96.6.1177","volume":"96","author":"J Yang","year":"1990","unstructured":"Yang J (1990) Ion permeation through 5-hydroxytryptamine-gated channels in neuroblastoma N18 cells. J Gen Physiol 96(6):1177\u20131198. https:\/\/doi.org\/10.1085\/jgp.96.6.1177","journal-title":"J Gen Physiol"},{"issue":"6717","key":"4438_CR116","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/16941","volume":"397","author":"PA Davies","year":"1999","unstructured":"Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF (1999) The 5-HT3B subunit is a major determinant of serotonin-receptor function. Nature 397(6717):359\u2013363. https:\/\/doi.org\/10.1038\/16941","journal-title":"Nature"},{"issue":"2","key":"4438_CR117","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1023\/b:ddas.0000017438.30998.08","volume":"49","author":"BN King","year":"2004","unstructured":"King BN, Stoner MC, Haque SM, Kellum JM (2004) A nitrergic secretomotor neurotransmitter in the chloride secretory response to serotonin. Dig Dis Sci 49(2):196\u2013201. https:\/\/doi.org\/10.1023\/b:ddas.0000017438.30998.08","journal-title":"Dig Dis Sci"},{"issue":"3","key":"4438_CR118","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1523\/JNEUROSCI.22-03-01010.2002","volume":"22","author":"KP Zeitz","year":"2002","unstructured":"Zeitz KP, Guy N, Malmberg AB, Dirajlal S, Martin WJ, Sun L, Bonhaus DW, Stucky CL, Julius D, Basbaum AI (2002) The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 22(3):1010\u20131019. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-03-01010.2002","journal-title":"J Neurosci"},{"issue":"2","key":"4438_CR119","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1179\/2045772315Y.0000000047","volume":"39","author":"F Nasirinezhad","year":"2016","unstructured":"Nasirinezhad F, Hosseini M, Karami Z, Yousefifard M, Janzadeh A (2016) Spinal 5-HT3 receptor mediates nociceptive effect on central neuropathic pain; possible therapeutic role for tropisetron. J Spinal Cord Med 39(2):212\u2013219. https:\/\/doi.org\/10.1179\/2045772315Y.0000000047","journal-title":"J Spinal Cord Med"},{"issue":"5","key":"4438_CR120","first-page":"910","volume":"55","author":"S Claeysen","year":"1999","unstructured":"Claeysen S, Sebben M, Becamel C, Bockaert J, Dumuis A (1999) Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: role of the C-terminal intracellular domain. Mol Pharmacol 55(5):910\u2013920","journal-title":"Mol Pharmacol"},{"issue":"1","key":"4438_CR121","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1124\/mol.61.1.85","volume":"61","author":"A Pindon","year":"2002","unstructured":"Pindon A, van Hecke G, van Gompel P, Lesage AS, Leysen JE, Jurzak M (2002) Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai\/o-proteins. Mol Pharmacol 61(1):85\u201396. https:\/\/doi.org\/10.1124\/mol.61.1.85","journal-title":"Mol Pharmacol"},{"issue":"18","key":"4438_CR122","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1038\/emboj.2009.215","volume":"28","author":"G Barthet","year":"2009","unstructured":"Barthet G, Carrat G, Cassier E, Barker B, Gaven F, Pillot M, Framery B, Pellissier LP, Augier J, Kang DS, Claeysen S, Reiter E, Ban\u00e8res JL, Benovic JL, Marin P, Bockaert J, Dumuis A (2009) Beta-arrestin1 phosphorylation by GRK5 regulates G protein-independent 5-HT4 receptor signalling. EMBO J 28(18):2706\u20132718. https:\/\/doi.org\/10.1038\/emboj.2009.215","journal-title":"EMBO J"},{"issue":"5","key":"4438_CR123","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.pharep.2017.04.001","volume":"69","author":"JB Pineda-Farias","year":"2017","unstructured":"Pineda-Farias JB, Barrag\u00e1n-Iglesias P, Valdivieso-S\u00e1nchez A, Rodr\u00edguez-Silverio J, Flores-Murrieta FJ, Granados-Soto V, Rocha-Gonz\u00e1lez HI (2017) Spinal 5-HT4 and 5-HT6 receptors contribute to the maintenance of neuropathic pain in rats. Pharmacol Rep 69(5):916\u2013923. https:\/\/doi.org\/10.1016\/j.pharep.2017.04.001","journal-title":"Pharmacol Rep"},{"issue":"1","key":"4438_CR124","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00005344-199307000-00008","volume":"22","author":"TA Bruning","year":"1993","unstructured":"Bruning TA, Chang PC, Blauw GJ, Vermeij P, van Zwieten PA (1993) Serotonin-induced vasodilatation in the human forearm is mediated by the \u201cnitric oxide-pathway\u201d: no evidence for involvement of the 5-HT3-receptor. J Cardiovasc Pharmacol 22(1):44\u201351. https:\/\/doi.org\/10.1097\/00005344-199307000-00008","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2\u20133","key":"4438_CR125","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0014-2999(98)00744-4","volume":"361","author":"BJ Francken","year":"1998","unstructured":"Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE (1998) The human 5-ht5A receptor couples to Gi\/Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur J Pharmacol 361(2\u20133):299\u2013309. https:\/\/doi.org\/10.1016\/s0014-2999(98)00744-4","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"4438_CR126","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1471-4159.2003.01518.x","volume":"84","author":"M Noda","year":"2003","unstructured":"Noda M, Yasuda S, Okada M, Higashida H, Shimada A, Iwata N, Ozaki N, Nishikawa K, Shirasawa S, Uchida M, Aoki S, Wada K (2003) Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways. J Neurochem 84(2):222\u2013232. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01518.x","journal-title":"J Neurochem"},{"issue":"4","key":"4438_CR127","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/cne.20214","volume":"476","author":"S Doly","year":"2004","unstructured":"Doly S, Fischer J, Brisorgueil MJ, Verg\u00e9 D, Conrath M (2004) 5-HT5A receptor localization in the rat spinal cord suggests a role in nociception and control of pelvic floor musculature. J Comp Neurol 476(4):316\u2013329. https:\/\/doi.org\/10.1002\/cne.20214","journal-title":"J Comp Neurol"},{"key":"4438_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2014.02.001","author":"E Mu\u00f1oz-Islas","year":"2014","unstructured":"Mu\u00f1oz-Islas E, Vidal-Cant\u00fa GC, Bravo-Hern\u00e1ndez M, Cervantes-Dur\u00e1n C, Qui\u00f1onez-Bastidas GN, Pineda-Farias JB, Barrag\u00e1n-Iglesias P, Granados-Soto V (2014) Spinal 5-HT5A receptors mediate 5-HT-induced antinociception in several pain models in rats. Pharmacol Biochem Behav. https:\/\/doi.org\/10.1016\/j.pbb.2014.02.001","journal-title":"Pharmacol Biochem Behav"},{"key":"4438_CR129","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1749-6632.1998.tb10178.x","volume":"861","author":"AJ Sleight","year":"1998","unstructured":"Sleight AJ, Boess FG, B\u00f6s M, Bourson A (1998) The putative 5-ht6 receptor: localization and function. Ann N Y Acad Sci 861:91\u201396. https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb10178.x","journal-title":"Ann N Y Acad Sci"},{"key":"4438_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-385902-0.00001-2","volume":"96","author":"LA Dawson","year":"2011","unstructured":"Dawson LA (2011) The central role of 5-HT6 receptors in modulating brain neurochemistry. Int Rev Neurobiol 96:1\u201326. https:\/\/doi.org\/10.1016\/B978-0-12-385902-0.00001-2","journal-title":"Int Rev Neurobiol"},{"issue":"12","key":"4438_CR131","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1172\/JCI70678","volume":"123","author":"HY Meltzer","year":"2013","unstructured":"Meltzer HY, Roth BL (2013) Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs. J Clin Invest 123(12):4986\u20134991. https:\/\/doi.org\/10.1172\/JCI70678","journal-title":"J Clin Invest"},{"issue":"2","key":"4438_CR132","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.neuroscience.2009.04.072","volume":"162","author":"G Casta\u00f1eda-Corral","year":"2009","unstructured":"Casta\u00f1eda-Corral G, Rocha-Gonz\u00e1lez HI, Araiza-Salda\u00f1a CI, Ambriz-Tututi M, Vidal-Cant\u00fa GC, Granados-Soto V (2009) Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test. Neuroscience 162(2):444\u2013452. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.04.072","journal-title":"Neuroscience"},{"issue":"6","key":"4438_CR133","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","volume":"33","author":"LE Schechter","year":"2008","unstructured":"Schechter LE, Lin Q, Smith DL, Zhang G, Shan Q, Platt B, Brandt MR, Dawson LA, Cole D, Bernotas R, Robichaud A, Rosenzweig-Lipson S, Beyer CE (2008) Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33(6):1323\u20131335. https:\/\/doi.org\/10.1038\/sj.npp.1301503","journal-title":"Neuropsychopharmacology"},{"key":"4438_CR134","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3389\/fnins.2020.00884","volume":"14","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yang J, Yang X, Wu Y, Liu J, Wang Y, Huo F, Yan C (2020) The 5-HT6 receptors in the ventrolateral orbital cortex attenuate allodynia in a rodent model of neuropathic pain. Front Neurosci 14:884. https:\/\/doi.org\/10.3389\/fnins.2020.00884","journal-title":"Front Neurosci"},{"issue":"2","key":"4438_CR135","first-page":"508","volume":"287","author":"N Adham","year":"1998","unstructured":"Adham N, Zgombick JM, Bard J, Branchek TA (1998) Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation. J Pharmacol Exp Ther 287(2):508\u2013514","journal-title":"J Pharmacol Exp Ther"},{"issue":"31","key":"4438_CR136","doi-asserted-by":"publisher","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","volume":"268","author":"JA Bard","year":"1993","unstructured":"Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (1993) Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 268(31):23422\u201323426","journal-title":"J Biol Chem"},{"issue":"5","key":"4438_CR137","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1074\/jbc.M206237200","volume":"278","author":"JH Norum","year":"2003","unstructured":"Norum JH, Hart K, Levy FO (2003) Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a). J Biol Chem 278(5):3098\u20133104. https:\/\/doi.org\/10.1074\/jbc.M206237200","journal-title":"J Biol Chem"},{"issue":"9","key":"4438_CR138","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1523\/JNEUROSCI.2765-11.2012","volume":"32","author":"F Kobe","year":"2012","unstructured":"Kobe F, Guseva D, Jensen TP, Wirth A, Renner U, Hess D, M\u00fcller M, Medrihan L, Zhang W, Zhang M, Braun K, Westerholz S, Herzog A, Radyushkin K, El-Kordi A, Ehrenreich H, Richter DW, Rusakov DA, Ponimaskin E (2012) 5-HT7R\/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci 32(9):2915\u20132930. https:\/\/doi.org\/10.1523\/JNEUROSCI.2765-11.2012","journal-title":"J Neurosci"},{"issue":"28","key":"4438_CR139","doi-asserted-by":"publisher","first-page":"17469","DOI":"10.1074\/jbc.273.28.17469","volume":"273","author":"LP Baker","year":"1998","unstructured":"Baker LP, Nielsen MD, Impey S, Metcalf MA, Poser SW, Chan G, Obrietan K, Hamblin MW, Storm DR (1998) Stimulation of type 1 and type 8 Ca2+\/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. J Biol Chem 273(28):17469\u201317476. https:\/\/doi.org\/10.1074\/jbc.273.28.17469","journal-title":"J Biol Chem"},{"issue":"3","key":"4438_CR140","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.bjp.0702580","volume":"127","author":"JA Terr\u00f3n","year":"1999","unstructured":"Terr\u00f3n JA, Falc\u00f3n-Neri A (1999) Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br J Pharmacol 127(3):609\u2013616. https:\/\/doi.org\/10.1038\/sj.bjp.0702580","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4438_CR141","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s0304-3940(01)01617-2","volume":"302","author":"JA Terr\u00f3n","year":"2001","unstructured":"Terr\u00f3n JA, Bouchelet I, Hamel E (2001) 5-HT7 receptor mRNA expression in human trigeminal ganglia. Neurosci Lett 302(1):9\u201312. https:\/\/doi.org\/10.1016\/s0304-3940(01)01617-2","journal-title":"Neurosci Lett"},{"issue":"7","key":"4438_CR142","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/sj.bjp.0701020","volume":"120","author":"CM Villal\u00f3n","year":"1997","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Luj\u00e1n-Estrada M, Terr\u00f3n JA, S\u00e1nchez-L\u00f3pez A (1997) Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor. Br J Pharmacol 120(7):1319\u20131327. https:\/\/doi.org\/10.1038\/sj.bjp.0701020","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4438_CR143","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12031-014-0268-9","volume":"54","author":"X Wang","year":"2014","unstructured":"Wang X, Fang Y, Liang J, Yan M, Hu R, Pan X (2014) 5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraine. J Mol Neurosci 54(2):164\u2013170. https:\/\/doi.org\/10.1007\/s12031-014-0268-9","journal-title":"J Mol Neurosci"},{"issue":"1","key":"4438_CR144","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/sj.bjp.0702055","volume":"125","author":"I Morecroft","year":"1998","unstructured":"Morecroft I, MacLean MR (1998) 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries. Br J Pharmacol 125(1):69\u201378. https:\/\/doi.org\/10.1038\/sj.bjp.0702055","journal-title":"Br J Pharmacol"},{"issue":"4","key":"4438_CR145","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1526-4610.2010.01632.x","volume":"50","author":"X Wang","year":"2010","unstructured":"Wang X, Fang Y, Liang J, Yin Z, Miao J, Luo N (2010) Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine. Headache 50(4):579\u2013587. https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01632.x","journal-title":"Headache"},{"issue":"1\u20133","key":"4438_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0014-2999(02)01436-x","volume":"439","author":"JA Terr\u00f3n","year":"2002","unstructured":"Terr\u00f3n JA (2002) Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine? Eur J Pharmacol 439(1\u20133):1\u201311. https:\/\/doi.org\/10.1016\/s0014-2999(02)01436-x","journal-title":"Eur J Pharmacol"},{"key":"4438_CR147","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-1-4615-4709-9_25","volume":"467","author":"DD Milovanovi\u0107","year":"1999","unstructured":"Milovanovi\u0107 DD, Majki\u0107-Sing N, Mirkovi\u0107 D, Pavlovi\u0107 J (1999) Plasma and urinary serotonin and 5-hydroxyindol-3-acetic acid in adults with migraine and tension-type headache. Adv Exp Med Biol 467:191\u2013197. https:\/\/doi.org\/10.1007\/978-1-4615-4709-9_25","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"4438_CR148","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1526-4610.1977.hed1701025.x","volume":"17","author":"MT Hyypp","year":"1977","unstructured":"Hyypp MT, Kangasniemi P (1977) Variation of plasma free tryptophan and CSF 5-HIAA during migraine. Headache 17(1):25\u201327. https:\/\/doi.org\/10.1111\/j.1526-4610.1977.hed1701025.x","journal-title":"Headache"},{"issue":"4","key":"4438_CR149","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1046\/j.1468-2982.1986.0604205.x","volume":"6","author":"MG Bousser","year":"1986","unstructured":"Bousser MG, Elghozi JL, Laude D, Soisson T (1986) Urinary 5-HIAA in migraine: evidence of lowered excretion in young adult females. Cephalalgia 6(4):205\u2013209. https:\/\/doi.org\/10.1046\/j.1468-2982.1986.0604205.x","journal-title":"Cephalalgia"},{"issue":"1","key":"4438_CR150","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/jnnp.29.1.85","volume":"29","author":"G Curzon","year":"1966","unstructured":"Curzon G, Theaker P, Phillips B (1966) Excretion of 5-hydroxyindolyl acetic acid (5HIAA) in migraine. J Neurol Neurosurg Psychiatry 29(1):85\u201390. https:\/\/doi.org\/10.1136\/jnnp.29.1.85","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4438_CR151","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1744-8069-7-21","volume":"7","author":"Y Chen","year":"2011","unstructured":"Chen Y, Palm F, Lesch KP, Gerlach M, Moessner R, Sommer C (2011) 5-hydroxyindolacetic acid (5-HIAA), a main metabolite of serotonin, is responsible for complete Freund\u2019s adjuvant-induced thermal hyperalgesia in mice. Mol Pain 7:21. https:\/\/doi.org\/10.1186\/1744-8069-7-21","journal-title":"Mol Pain"},{"issue":"2","key":"4438_CR152","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5152\/eurasianjmed.2015.0267","volume":"48","author":"M Emet","year":"2016","unstructured":"Emet M, Ozcan H, Ozel L, Yayla M, Halici Z, Hacimuftuoglu A (2016) A review of melatonin, its receptors and drugs. Eurasian J Med 48(2):135\u2013141. https:\/\/doi.org\/10.5152\/eurasianjmed.2015.0267","journal-title":"Eurasian J Med"},{"issue":"8","key":"4438_CR153","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1021\/jm401343c","volume":"57","author":"DP Zlotos","year":"2014","unstructured":"Zlotos DP, Jockers R, Cecon E, Rivara S, Witt-Enderby PA (2014) MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential. J Med Chem 57(8):3161\u20133185. https:\/\/doi.org\/10.1021\/jm401343c","journal-title":"J Med Chem"},{"issue":"1","key":"4438_CR154","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/BJ20071373","volume":"413","author":"B Calamini","year":"2008","unstructured":"Calamini B, Santarsiero BD, Boutin JA, Mesecar AD (2008) Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2. Biochem J 413(1):81\u201391. https:\/\/doi.org\/10.1042\/BJ20071373","journal-title":"Biochem J"},{"issue":"12","key":"4438_CR155","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1210\/mend.13.12.0390","volume":"13","author":"L Brydon","year":"1999","unstructured":"Brydon L, Roka F, Petit L, de Coppet P, Tissot M, Barrett P, Morgan PJ, Nanoff C, Strosberg AD, Jockers R (1999) Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q\/11) proteins. Mol Endocrinol 13(12):2025\u20132038. https:\/\/doi.org\/10.1210\/mend.13.12.0390","journal-title":"Mol Endocrinol"},{"issue":"9","key":"4438_CR156","doi-asserted-by":"publisher","first-page":"18385","DOI":"10.3390\/ijms140918385","volume":"14","author":"KH Chan","year":"2013","unstructured":"Chan KH, Wong YH (2013) A molecular and chemical perspective in defining melatonin receptor subtype selectivity. Int J Mol Sci 14(9):18385\u201318406. https:\/\/doi.org\/10.3390\/ijms140918385","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4438_CR157","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/biot.200900016","volume":"4","author":"M Kamal","year":"2009","unstructured":"Kamal M, Marquez M, Vauthier V, Leloire A, Froguel P, Jockers R, Couturier C (2009) Improved donor\/acceptor BRET couples for monitoring beta-arrestin recruitment to G protein-coupled receptors. Biotechnol J 4(9):1337\u20131344. https:\/\/doi.org\/10.1002\/biot.200900016","journal-title":"Biotechnol J"},{"issue":"1","key":"4438_CR158","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0014-2999(98)00064-8","volume":"345","author":"S Doolen","year":"1998","unstructured":"Doolen S, Krause DN, Dubocovich ML, Duckles SP (1998) Melatonin mediates two distinct responses in vascular smooth muscle. Eur J Pharmacol 345(1):67\u201369. https:\/\/doi.org\/10.1016\/s0014-2999(98)00064-8","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"4438_CR159","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4449\/aib.v150i4.1391","volume":"150","author":"V Srinivasan","year":"2012","unstructured":"Srinivasan V, Zakaria R, Jeet Singh H, Acuna-Castroviejo D (2012) Melatonin and its agonists in pain modulation and its clinical application. Arch Ital Biol 150(4):274\u2013289. https:\/\/doi.org\/10.4449\/aib.v150i4.1391","journal-title":"Arch Ital Biol"},{"issue":"32","key":"4438_CR160","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.2174\/0929867324666170209104926","volume":"25","author":"L Posa","year":"2018","unstructured":"Posa L, De Gregorio D, Gobbi G, Comai S (2018) Targeting melatonin MT2 receptors: a novel pharmacological avenue for inflammatory and neuropathic pain. Curr Med Chem 25(32):3866\u20133882. https:\/\/doi.org\/10.2174\/0929867324666170209104926","journal-title":"Curr Med Chem"},{"issue":"3","key":"4438_CR161","doi-asserted-by":"publisher","first-page":"e12671","DOI":"10.1111\/jpi.12671","volume":"69","author":"L Posa","year":"2020","unstructured":"Posa L, Lopez-Canul M, Rullo L, De Gregorio D, Dominguez-Lopez S, Kaba Aboud M, Caputi FF, Candeletti S, Romualdi P, Gobbi G (2020) Nociceptive responses in melatonin MT2 receptor knockout mice compared to MT1 and double MT1 \/MT2 receptor knockout mice. J Pineal Res 69(3):e12671. https:\/\/doi.org\/10.1111\/jpi.12671","journal-title":"J Pineal Res"},{"issue":"2","key":"4438_CR162","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1385\/ENDO:27:2:101","volume":"27","author":"ML Dubocovich","year":"2005","unstructured":"Dubocovich ML, Markowska M (2005) Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27(2):101\u2013110. https:\/\/doi.org\/10.1385\/ENDO:27:2:101","journal-title":"Endocrine"},{"issue":"4","key":"4438_CR163","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1124\/pr.110.002667","volume":"62","author":"NJ Smith","year":"2010","unstructured":"Smith NJ, Milligan G (2010) Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes. Pharmacol Rev 62(4):701\u2013725. https:\/\/doi.org\/10.1124\/pr.110.002667","journal-title":"Pharmacol Rev"},{"issue":"2","key":"4438_CR164","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1124\/mol.104.000398","volume":"66","author":"MA Ayoub","year":"2004","unstructured":"Ayoub MA, Levoye A, Delagrange P, Jockers R (2004) Preferential formation of MT1\/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol Pharmacol 66(2):312\u2013321. https:\/\/doi.org\/10.1124\/mol.104.000398","journal-title":"Mol Pharmacol"},{"issue":"296","key":"4438_CR165","doi-asserted-by":"publisher","first-page":"ra89","DOI":"10.1126\/scisignal.2004302","volume":"6","author":"K Baba","year":"2013","unstructured":"Baba K, Benleulmi-Chaachoua A, Journ\u00e9 AS, Kamal M, Guillaume JL, Dussaud S, Gbahou F, Yettou K, Liu C, Contreras-Alcantara S, Jockers R, Tosini G (2013) Heteromeric MT1\/MT2 melatonin receptors modulate photoreceptor function. Sci Signal 6(296):ra89. https:\/\/doi.org\/10.1126\/scisignal.2004302","journal-title":"Sci Signal"},{"issue":"18","key":"4438_CR166","doi-asserted-by":"publisher","first-page":"11537","DOI":"10.1074\/jbc.M114.559542","volume":"290","author":"M Kamal","year":"2015","unstructured":"Kamal M, Gbahou F, Guillaume JL, Daulat AM, Benleulmi-Chaachoua A, Luka M, Chen P, Kalbasi Anaraki D, Baroncini M, Mannoury la Cour C, Millan MJ, Prevot V, Delagrange P, Jockers R (2015) Convergence of melatonin and serotonin (5-HT) signaling at MT2\/5-HT2C receptor heteromers. J Biol Chem 290(18):11537\u201311546. https:\/\/doi.org\/10.1074\/jbc.M114.559542","journal-title":"J Biol Chem"},{"issue":"3","key":"4438_CR167","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.117.015305","volume":"70","author":"RR Gainetdinov","year":"2018","unstructured":"Gainetdinov RR, Hoener MC, Berry MD (2018) Trace amines and their receptors. Pharmacol Rev 70(3):549\u2013620. https:\/\/doi.org\/10.1124\/pr.117.015305","journal-title":"Pharmacol Rev"},{"issue":"1","key":"4438_CR168","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-0773.1987.tb01711.x","volume":"60","author":"MM Airaksinen","year":"1987","unstructured":"Airaksinen MM, Lecklin A, Saano V, Tuomisto L, Gynther J (1987) Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by beta-carbolines. Pharmacol Toxicol 60(1):5\u20138. https:\/\/doi.org\/10.1111\/j.1600-0773.1987.tb01711.x","journal-title":"Pharmacol Toxicol"},{"issue":"3","key":"4438_CR169","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1254\/jjp.51.421","volume":"51","author":"J Yamada","year":"1989","unstructured":"Yamada J, Sugimoto Y, Horisaka K (1989) The evidence for the involvement of the 5-HT1A receptor in 5-HT syndrome induced in mice by tryptamine. Jpn J Pharmacol 51(3):421\u2013424. https:\/\/doi.org\/10.1254\/jjp.51.421","journal-title":"Jpn J Pharmacol"},{"issue":"1\u20132","key":"4438_CR170","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.vph.2012.10.007","volume":"58","author":"MA Anwar","year":"2013","unstructured":"Anwar MA, Ford WR, Herbert AA, Broadley KJ (2013) Signal transduction and modulating pathways in tryptamine-evoked vasopressor responses of the rat isolated perfused mesenteric bed. Vascul Pharmacol 58(1\u20132):140\u2013149. https:\/\/doi.org\/10.1016\/j.vph.2012.10.007","journal-title":"Vascul Pharmacol"},{"issue":"16","key":"4438_CR171","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1073\/pnas.151105198","volume":"98","author":"B Borowsky","year":"2001","unstructured":"Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98(16):8966\u20138971. https:\/\/doi.org\/10.1073\/pnas.151105198","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"4438_CR172","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ygeno.2004.11.010","volume":"85","author":"L Lindemann","year":"2005","unstructured":"Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC (2005) Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85(3):372\u2013385. https:\/\/doi.org\/10.1016\/j.ygeno.2004.11.010","journal-title":"Genomics"},{"issue":"11","key":"4438_CR173","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1177\/0333102413480755","volume":"33","author":"G D'Andrea","year":"2013","unstructured":"D\u2019Andrea G, D\u2019Amico D, Bussone G, Bolner A, Aguggia M, Saracco MG, Galloni E, De Riva V, Colavito D, Leon A, Rosteghin V, Perini F (2013) The role of tyrosine metabolism in the pathogenesis of chronic migraine. Cephalalgia 33(11):932\u2013937. https:\/\/doi.org\/10.1177\/0333102413480755","journal-title":"Cephalalgia"},{"issue":"1","key":"4438_CR174","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1526-4610.1974.hed1401043.x","volume":"14","author":"RE Ryan Jr","year":"1974","unstructured":"Ryan RE Jr (1974) A clinical study of tyramine as an etiological factor in migraine. Headache 14(1):43\u201348. https:\/\/doi.org\/10.1111\/j.1526-4610.1974.hed1401043.x","journal-title":"Headache"},{"issue":"10","key":"4438_CR175","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1212\/01.wnl.0000125188.79106.29","volume":"62","author":"G D'Andrea","year":"2004","unstructured":"D\u2019Andrea G, Terrazzino S, Leon A, Fortin D, Perini F, Granella F, Bussone G (2004) Elevated levels of circulating trace amines in primary headaches. Neurology 62(10):1701\u20131705. https:\/\/doi.org\/10.1212\/01.wnl.0000125188.79106.29","journal-title":"Neurology"},{"issue":"8","key":"4438_CR176","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1468-2982.2006.01141.x","volume":"26","author":"G D'Andrea","year":"2006","unstructured":"D\u2019Andrea G, Granella F, Leone M, Perini F, Farruggio A, Bussone G (2006) Abnormal platelet trace amine profiles in migraine with and without aura. Cephalalgia 26(8):968\u2013972. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01141.x","journal-title":"Cephalalgia"},{"issue":"5551","key":"4438_CR177","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/bmj.2.5551.550","volume":"2","author":"E Hannington","year":"1967","unstructured":"Hannington E (1967) Preliminary report on tyramine headache. Br Med J 2(5551):550\u2013551. https:\/\/doi.org\/10.1136\/bmj.2.5551.550","journal-title":"Br Med J"},{"issue":"464","key":"4438_CR178","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/250335a0","volume":"250","author":"M Sandler","year":"1974","unstructured":"Sandler M, Youdim MB, Hanington E (1974) A phenylethylamine oxidising defect in migraine. Nature 250(464):335\u2013337. https:\/\/doi.org\/10.1038\/250335a0","journal-title":"Nature"},{"issue":"5","key":"4438_CR179","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/AJP.0b013e31819a6f65","volume":"25","author":"C Sun-Edelstein","year":"2009","unstructured":"Sun-Edelstein C, Christina MD, Mauskop AMD (2009) Foods and supplements in the management of migraine headaches. Clin J Pain 25(5):446\u2013452. https:\/\/doi.org\/10.1097\/AJP.0b013e31819a6f65","journal-title":"Clin J Pain"},{"issue":"9","key":"4438_CR180","first-page":"4409","volume":"4","author":"M Irsfeld","year":"2013","unstructured":"Irsfeld M, Spadafore M, Pr\u00fc\u00df BM (2013) \u03b2-phenylethylamine, a small molecule with a large impact. Webmedcentral 4(9):4409","journal-title":"Webmedcentral"},{"issue":"9","key":"4438_CR181","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1212\/wnl.27.9.817","volume":"27","author":"J McCulloch","year":"1977","unstructured":"McCulloch J, Harper AM (1977) Phenylethylamine and cerebral blood flow. Possible involvement of phenylethylamine in migraine. Neurology 27(9):817\u2013821. https:\/\/doi.org\/10.1212\/wnl.27.9.817","journal-title":"Neurology"},{"issue":"2","key":"4438_CR182","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2222.1982.tb01633.x","volume":"12","author":"RV Heatley","year":"1982","unstructured":"Heatley RV, Denburg JA, Bayer N, Bienenstock J (1982) Increased plasma histamine levels in migraine patients. Clin Allergy 12(2):145\u2013149. https:\/\/doi.org\/10.1111\/j.1365-2222.1982.tb01633.x","journal-title":"Clin Allergy"},{"issue":"1","key":"4438_CR183","first-page":"17","volume":"2","author":"P Gazerani","year":"2003","unstructured":"Gazerani P, Pourpak Z, Ahmadiani A, Hemmati A, Kazemnejad A (2003) A correlation between migraine, histamine and immunoglobulin E. Iran J Allergy Asthma Immunol 2(1):17\u201324","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"2","key":"4438_CR184","doi-asserted-by":"publisher","first-page":"57","DOI":"10.7860\/JCDR\/2014\/7516.4007","volume":"8","author":"D Rosario","year":"2004","unstructured":"Rosario D, Pinto G (2004) Role of gender and serum Immunoglobulin E (IGE) levels on severity of migraine. J Clin Diagn Res 8(2):57\u201358. https:\/\/doi.org\/10.7860\/JCDR\/2014\/7516.4007","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"4438_CR185","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000237304","volume":"110","author":"R Jarisch","year":"1996","unstructured":"Jarisch R, Wantke F (1996) Wine and headache. Int Arch Allergy Immunol 110(1):7\u201312. https:\/\/doi.org\/10.1159\/000237304","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"4438_CR186","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1365-2222.1993.tb00287.x","volume":"23","author":"F Wantke","year":"1993","unstructured":"Wantke F, G\u00f6tz M, Jarisch R (1993) Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronic headaches. Clin Exp Allergy 23(12):982\u2013985. https:\/\/doi.org\/10.1111\/j.1365-2222.1993.tb00287.x","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"4438_CR187","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.bjp.0706948","volume":"149","author":"R Zucchi","year":"2006","unstructured":"Zucchi R, Chiellini G, Scanlan TS, Grandy DK (2006) Trace amine-associated receptors and their ligands. Br J Pharmacol 149(8):967\u2013978. https:\/\/doi.org\/10.1038\/sj.bjp.0706948","journal-title":"Br J Pharmacol"},{"issue":"11","key":"4438_CR188","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.euroneuro.2015.08.011","volume":"25","author":"A Harmeier","year":"2015","unstructured":"Harmeier A, Obermueller S, Meyer CA, Revel FG, Buchy D, Chaboz S, Dernick G, Wettstein JG, Iglesias A, Rolink A, Bettler B, Hoener MC (2015) Trace amine-associated receptor 1 activation silences GSK3\u03b2 signaling of TAAR1 and D2R heteromers. Eur Neuropsychopharmacol 25(11):2049\u20132061. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.08.011","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"4438_CR189","doi-asserted-by":"publisher","first-page":"10925","DOI":"10.1038\/s41598-019-46627-5","volume":"9","author":"AHW Koh","year":"2019","unstructured":"Koh AHW, Chess-Williams R, Lohning AE (2019) Differential mechanisms of action of the trace amines octopamine, synephrine and tyramine on the porcine coronary and mesenteric artery. Sci Rep 9(1):10925. https:\/\/doi.org\/10.1038\/s41598-019-46627-5","journal-title":"Sci Rep"},{"key":"4438_CR190","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ejphar.2017.10.038","volume":"818","author":"KJ Broadley","year":"2018","unstructured":"Broadley KJ, Broadley HD (2018) Non-adrenergic vasoconstriction and vasodilatation of guinea-pig aorta by \u03b2-phenylethylamine and amphetamine\u2014role of nitric oxide determined with L-NAME and NO scavengers. Eur J Pharmacol 818:198\u2013205. https:\/\/doi.org\/10.1016\/j.ejphar.2017.10.038","journal-title":"Eur J Pharmacol"},{"key":"4438_CR191","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuropharm.2014.02.007","volume":"81","author":"D Leo","year":"2014","unstructured":"Leo D, Mus L, Espinoza S, Hoener MC, Sotnikova TD, Gainetdinov RR (2014) Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology 81:283\u2013291. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.02.007","journal-title":"Neuropharmacology"},{"issue":"5","key":"4438_CR192","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1586\/14737175.8.5.781","volume":"8","author":"PB Wood","year":"2008","unstructured":"Wood PB (2008) Role of central dopamine in pain and analgesia. Expert Rev Neurother 8(5):781\u2013797. https:\/\/doi.org\/10.1586\/14737175.8.5.781","journal-title":"Expert Rev Neurother"},{"issue":"17","key":"4438_CR193","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1212\/WNL.0000000000003861","volume":"88","author":"AF DaSilva","year":"2017","unstructured":"DaSilva AF, Nascimento TD, Jassar H, Heffernan J, Toback RL, Lucas S, DosSantos MF, Bellile EL, Boonstra PS, Taylor JMG, Casey KL, Koeppe RA, Smith YR, Zubieta JK (2017) Dopamine D2\/D3 imbalance during migraine attack and allodynia in vivo. Neurology 88(17):1634\u20131641. https:\/\/doi.org\/10.1212\/WNL.0000000000003861","journal-title":"Neurology"},{"issue":"11","key":"4438_CR194","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1001\/archneur.61.11.1705","volume":"61","author":"S Thobois","year":"2004","unstructured":"Thobois S, Vingerhoets F, Fraix V, Xie-Brustolin J, Mollion H, Costes N, Mertens P, Benabid AL, Pollak P, Broussolle E (2004) Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study. Arch Neurol 61(11):1705\u20131709. https:\/\/doi.org\/10.1001\/archneur.61.11.1705","journal-title":"Arch Neurol"},{"issue":"6","key":"4438_CR195","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1096\/fj.201600755RR","volume":"31","author":"SA Lee","year":"2017","unstructured":"Lee SA, Suh Y, Lee S, Jeong J, Kim SJ, Kim SJ, Park SK (2017) Functional expression of dopamine D2 receptor is regulated by tetraspanin 7-mediated postendocytic trafficking. FASEB J 31(6):2301\u20132313. https:\/\/doi.org\/10.1096\/fj.201600755RR","journal-title":"FASEB J"},{"issue":"1","key":"4438_CR196","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1007\/s00011-007-0621-3","volume":"57","author":"RG Booth","year":"2008","unstructured":"Booth RG, Fang L, Wilczynski A, Sivendren S, Sun Z, Travers S, Bruysters M, Sansuk K, Leurs R (2008) Molecular determinants of ligand-directed signaling for the histamine H1 receptor. Inflamm Res 57(1):S43-44. https:\/\/doi.org\/10.1007\/s00011-007-0621-3","journal-title":"Inflamm Res"},{"issue":"Suppl 1","key":"4438_CR197","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1038\/sj.bjp.0706440","volume":"147","author":"ME Parsons","year":"2006","unstructured":"Parsons ME, Ganellin CR (2006) Histamine and its receptors. Br J Pharmacol 147(Suppl 1):S127-135. https:\/\/doi.org\/10.1038\/sj.bjp.0706440","journal-title":"Br J Pharmacol"},{"issue":"3","key":"4438_CR198","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1067\/mai.2002.121944","volume":"109","author":"R Gutzmer","year":"2002","unstructured":"Gutzmer R, Langer K, Lisewski M, Mommert S, Rieckborn D, Kapp A, Werfel T (2002) Expression and function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol 109(3):524\u2013531. https:\/\/doi.org\/10.1067\/mai.2002.121944","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4438_CR199","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/head.13164","volume":"58","author":"H Yuan","year":"2018","unstructured":"Yuan H, Silberstein SD (2018) Histamine and Migraine. Headache 58(1):184\u2013193. https:\/\/doi.org\/10.1111\/head.13164","journal-title":"Headache"},{"issue":"1","key":"4438_CR200","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1124\/jpet.104.070086","volume":"311","author":"NH Moniri","year":"2004","unstructured":"Moniri NH, Covington-Strachan D, Booth RG (2004) Ligand-directed functional heterogeneity of histamine H1 receptors: novel dual-function ligands selectively activate and block H1-mediated phospholipase C and adenylyl cyclase signaling. J Pharmacol Exp Ther 311(1):274\u2013281. https:\/\/doi.org\/10.1124\/jpet.104.070086","journal-title":"J Pharmacol Exp Ther"},{"key":"4438_CR201","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/978-3-0348-7309-3_20","volume":"33","author":"M Mitsuhashi","year":"1989","unstructured":"Mitsuhashi M, Mitsuhashi T, Payan DG (1989) Multiple signaling pathways of histamine H2 receptors. Agents Actions Suppl 33:289\u2013294. https:\/\/doi.org\/10.1007\/978-3-0348-7309-3_20","journal-title":"Agents Actions Suppl"},{"issue":"6814","key":"4438_CR202","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35048583","volume":"408","author":"S Morisset","year":"2000","unstructured":"Morisset S, Rouleau A, Ligneau X, Gbahou F, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM (2000) High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature 408(6814):860\u2013864. https:\/\/doi.org\/10.1038\/35048583","journal-title":"Nature"},{"key":"4438_CR203","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0531-5131(03)00617-4","volume":"1249","author":"JM Arrang","year":"2003","unstructured":"Arrang JM, Morisset S, Rouleau A, Gbahou F, Ligneau X, Tardivel-Lacombe J, Stark H, Schunack E, Ganellin CR, Schwartz J (2003) Constitutive activity of the recombinant and native histamine H3 receptor. Int Congr Ser 1249:139\u2013151. https:\/\/doi.org\/10.1016\/S0531-5131(03)00617-4","journal-title":"Int Congr Ser"},{"issue":"6","key":"4438_CR204","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1124\/mol.55.6.1101","volume":"55","author":"TW Lovenberg","year":"1999","unstructured":"Lovenberg TW, Roland BL, Wilson SJ, Jiang X, Pyati J, Huvar A, Jackson MR, Erlander MG (1999) Cloning and functional expression of the human histamine H3 receptor. Mol Pharmacol 55(6):1101\u20131107. https:\/\/doi.org\/10.1124\/mol.55.6.1101","journal-title":"Mol Pharmacol"},{"key":"4438_CR205","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2008.11.018","volume":"1250","author":"MI Strakhova","year":"2009","unstructured":"Strakhova MI, Nikkel AL, Manelli AM, Hsieh GC, Esbenshade TA, Brioni JD, Bitner RS (2009) Localization of histamine H4 receptors in the central nervous system of human and rat. Brain Res 1250:41\u201348. https:\/\/doi.org\/10.1016\/j.brainres.2008.11.018","journal-title":"Brain Res"},{"issue":"6","key":"4438_CR206","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1021\/bi802050d","volume":"48","author":"EH Schneider","year":"2009","unstructured":"Schneider EH, Schnell D, Papa D, Seifert R (2009) High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor. Biochemistry 48(6):1424\u20131438. https:\/\/doi.org\/10.1021\/bi802050d","journal-title":"Biochemistry"},{"issue":"2","key":"4438_CR207","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/head.12293","volume":"54","author":"KB Alstadhaug","year":"2014","unstructured":"Alstadhaug KB (2014) Histamine in migraine and brain. Headache 54(2):246\u2013259. https:\/\/doi.org\/10.1111\/head.12293","journal-title":"Headache"},{"issue":"1","key":"4438_CR208","first-page":"7","volume":"29","author":"AB Ebeigbe","year":"2014","unstructured":"Ebeigbe AB, Talabi OO (2014) Vascular effects of histamine. Niger J Physiol Sci 29(1):7\u201310","journal-title":"Niger J Physiol Sci"},{"issue":"Pt 2","key":"4438_CR209","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1113\/jphysiol.2004.080325","volume":"563","author":"JM Lockwood","year":"2004","unstructured":"Lockwood JM, Wilkins BW, Halliwill JR (2004) H1 receptor-mediated vasodilatation contributes to postexercise hypotension. J Physiol 563(Pt 2):633\u2013642. https:\/\/doi.org\/10.1113\/jphysiol.2004.080325","journal-title":"J Physiol"},{"issue":"1","key":"4438_CR210","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0014-2999(99)00598-1","volume":"383","author":"HA Campos","year":"1999","unstructured":"Campos HA, Montenegro M, Velasco M, Romero E, Alvarez R, Urbina A (1999) Treadmill exercise-induced stress causes a rise of blood histamine in normotensive but not in primary hypertensive humans. Eur J Pharmacol 383(1):69\u201373. https:\/\/doi.org\/10.1016\/s0014-2999(99)00598-1","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4438_CR211","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0014-2999(97)10105-4","volume":"329","author":"S Chiba","year":"1997","unstructured":"Chiba S, Tsukada M (1997) Mechanisms for histamine H1 receptor-mediated vasodilation in isolated canine lingual arteries. Eur J Pharmacol 329(1):63\u201368. https:\/\/doi.org\/10.1016\/s0014-2999(97)10105-4","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4438_CR212","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0009-9236(95)90074-8","volume":"58","author":"G Bedarida","year":"1995","unstructured":"Bedarida G, Bushell E, Blaschke TF, Hoffman BB (1995) H1- and H2-histamine receptor-mediated vasodilation varies with aging in humans. Clin Pharmacol Ther 58(1):73\u201380. https:\/\/doi.org\/10.1016\/0009-9236(95)90074-8","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"4438_CR213","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/ajcn\/85.5.1185","volume":"85","author":"L Maintz","year":"2007","unstructured":"Maintz L, Novak N (2007) Histamine and histamine intolerance. Am J Clin Nutr 85(5):1185\u20131196. https:\/\/doi.org\/10.1093\/ajcn\/85.5.1185","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"4438_CR214","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/s0317167100004960","volume":"33","author":"RO Millan-Guerrero","year":"2006","unstructured":"Millan-Guerrero RO, Isais-Mill\u00e1n R, Benjam\u00edn TH, Tene CE (2006) Nalpha-methyl histamine safety and efficacy in migraine prophylaxis: phase III study. Can J Neurol Sci 33(2):195\u2013199. https:\/\/doi.org\/10.1017\/s0317167100004960","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"4438_CR215","first-page":"43","volume":"287","author":"RL McLeod","year":"1998","unstructured":"McLeod RL, Aslanian R, del Prado M, Duffy R, Egan RW, Kreutner W, McQuade R, Hey JA (1998) Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig. J Pharmacol Exp Ther 287(1):43\u201350","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"4438_CR216","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.arcmed.2011.01.009","volume":"42","author":"RO Mill\u00e1n-Guerrero","year":"2011","unstructured":"Mill\u00e1n-Guerrero RO, Baltazar-Rodr\u00edguez LM, C\u00e1rdenas-Rojas MI, Ram\u00edrez-Flores M, Isais-Mill\u00e1n S, Delgado-Enciso I, Caballero-Hoyos R, Trujillo-Hern\u00e1ndez B (2011) A280V polymorphism in the histamine H3 receptor as a risk factor for migraine. Arch Med Res 42(1):44\u201347. https:\/\/doi.org\/10.1016\/j.arcmed.2011.01.009","journal-title":"Arch Med Res"},{"issue":"4","key":"4438_CR217","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/life10040050","volume":"10","author":"P Mehta","year":"2020","unstructured":"Mehta P, Miszta P, Rzodkiewicz P, Michalak O, Krzeczy\u0144ski P, Filipek S (2020) Enigmatic histamine receptor H4 for potential treatment of multiple inflammatory, autoimmune, and related diseases. Life 10(4):50. https:\/\/doi.org\/10.3390\/life10040050","journal-title":"Life"},{"key":"4438_CR218","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2016.11.023","volume":"114","author":"MD Sanna","year":"2017","unstructured":"Sanna MD, Ghelardini C, Thurmond RL, Masini E, Galeotti N (2017) Behavioral phenotype of histamine H4 receptor knockout mice: focus on central neuronal functions. Neuropharmacology 114:48\u201357. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.11.023","journal-title":"Neuropharmacology"},{"issue":"6","key":"4438_CR219","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1159\/000125048","volume":"14","author":"FM Smith","year":"2007","unstructured":"Smith FM, Haskelberg H, Tracey DJ, Moalem-Taylor G (2007) Role of histamine H3 and H4 receptors in mechanical hyperalgesia following peripheral nerve injury. NeuroImmunoModulation 14(6):317\u2013325. https:\/\/doi.org\/10.1159\/000125048","journal-title":"NeuroImmunoModulation"},{"issue":"14","key":"4438_CR220","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1111\/bph.14185","volume":"175","author":"K Popiolek-Barczyk","year":"2018","unstructured":"Popiolek-Barczyk K, \u0141a\u017cewska D, Latacz G, Olejarz A, Makuch W, Stark H, Kie\u0107-Kononowicz K, Mika J (2018) Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse. Br J Pharmacol 175(14):2897\u20132910. https:\/\/doi.org\/10.1111\/bph.14185","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4438_CR221","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrd2466","volume":"7","author":"JO Lundberg","year":"2008","unstructured":"Lundberg JO, Weitzberg E, Gladwin MT (2008) The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7(2):156\u2013167. https:\/\/doi.org\/10.1038\/nrd2466","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"4438_CR222","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nchembio813","volume":"2","author":"S Shiva","year":"2006","unstructured":"Shiva S, Wang X, Ringwood LA, Xu X, Yuditskaya S, Annavajjhala V, Miyajima H, Hogg N, Harris ZL, Gladwin MT (2006) Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol 2(9):486\u2013493. https:\/\/doi.org\/10.1038\/nchembio813","journal-title":"Nat Chem Biol"},{"key":"4438_CR223","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05672-7","author":"G D'Andrea","year":"2021","unstructured":"D\u2019Andrea G, Gucciardi A, Giordano G, Bussone G, Leon A (2021) Study of arginine metabolism in medication overuse chronic migraine: possible defect in NO synthesis. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-021-05672-7","journal-title":"Neurol Sci"},{"issue":"5","key":"4438_CR224","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1046\/j.1468-2982.1994.1405352.x","volume":"14","author":"G D'Andrea","year":"1994","unstructured":"D\u2019Andrea G, Cananzi AR, Perini F, Alecci M, Zamberlan F, Hasselmark L, Welch KM (1994) Decreased collagen-induced platelet aggregation and increased platelet arginine levels in migraine: a possible link with the NO pathway. Cephalalgia 14(5):352\u2013356. https:\/\/doi.org\/10.1046\/j.1468-2982.1994.1405352.x","journal-title":"Cephalalgia"},{"issue":"2","key":"4438_CR225","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1600-0404.1996.tb07046.x","volume":"94","author":"V Gallai","year":"1996","unstructured":"Gallai V, Floridi A, Mazzotta G, Codini M, Tognoloni M, Vulcano MR, Sartori M, Russo S, Alberti A, Michele F, Sarchielli P (1996) L-arginine\/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand 94(2):151\u2013160. https:\/\/doi.org\/10.1111\/j.1600-0404.1996.tb07046.x","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"4438_CR226","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1006\/bbrc.1995.1541","volume":"209","author":"PM Rhodes","year":"1995","unstructured":"Rhodes PM, Leone AM, Francis PL, Struthers AD, Moncada S (1995) The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 209(2):590\u2013596. https:\/\/doi.org\/10.1006\/bbrc.1995.1541","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4438_CR227","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1468-2982.2002.00304.x","volume":"22","author":"D D'Amico","year":"2002","unstructured":"D\u2019Amico D, Ferraris A, Leone M, Catania A, Carlin A, Grazzi L, Bussone G (2002) Increased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway? Cephalalgia 22(1):33\u201336. https:\/\/doi.org\/10.1046\/j.1468-2982.2002.00304.x","journal-title":"Cephalalgia"},{"issue":"5","key":"4438_CR228","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1526-4610.2001.01085.x","volume":"41","author":"R Shukla","year":"2001","unstructured":"Shukla R, Barthwal MK, Srivastava N, Nag D, Seth PK, Srimal RC, Dikshit M (2001) Blood nitrite levels in patients with migraine during headache-free period. Headache 41(5):475\u2013481. https:\/\/doi.org\/10.1046\/j.1526-4610.2001.01085.x","journal-title":"Headache"},{"issue":"7","key":"4438_CR229","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s10072-017-2970-1","volume":"38","author":"A Reyhani","year":"2017","unstructured":"Reyhani A, Celik Y, Karadag H, Gunduz O, Asil T, Sut N (2017) High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients. Neurol Sci 38(7):1287\u20131291. https:\/\/doi.org\/10.1007\/s10072-017-2970-1","journal-title":"Neurol Sci"},{"issue":"6","key":"4438_CR230","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1177\/0333102416651454","volume":"37","author":"S Erd\u00e9lyi-B\u00f3tor","year":"2017","unstructured":"Erd\u00e9lyi-B\u00f3tor S, Kom\u00e1romy H, Kamson DO, Kov\u00e1cs N, Perlaki G, Orsi G, Moln\u00e1r T, Illes Z, Nagy L, K\u00e9ki S, Deli G, Bosny\u00e1k E, Trauninger A, Pfund Z (2017) Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions. Cephalalgia 37(6):571\u2013580. https:\/\/doi.org\/10.1177\/0333102416651454","journal-title":"Cephalalgia"},{"issue":"27","key":"4438_CR231","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","volume":"329","author":"S Moncada","year":"1993","unstructured":"Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329(27):2002\u20132012. https:\/\/doi.org\/10.1056\/NEJM199312303292706","journal-title":"N Engl J Med"},{"issue":"2","key":"4438_CR232","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2165\/00148581-200911020-00003","volume":"11","author":"R Tulloh","year":"2009","unstructured":"Tulloh R (2009) Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension. Paediatr Drugs 11(2):115\u2013128. https:\/\/doi.org\/10.2165\/00148581-200911020-00003","journal-title":"Paediatr Drugs"},{"issue":"2","key":"4438_CR233","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2015.09.002","volume":"129","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Vanhoutte PM, Leung SW (2015) Vascular nitric oxide: beyond eNOS. J Pharmacol Sci 129(2):83\u201394. https:\/\/doi.org\/10.1016\/j.jphs.2015.09.002","journal-title":"J Pharmacol Sci"},{"issue":"7","key":"4438_CR234","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829\u2013837. https:\/\/doi.org\/10.1093\/eurheartj\/ehr304","journal-title":"Eur Heart J"},{"issue":"2","key":"4438_CR235","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13311-018-0614-7","volume":"15","author":"AA Pradhan","year":"2018","unstructured":"Pradhan AA, Bertels Z, Akerman S (2018) Targeted nitric oxide synthase inhibitors for migraine. Neurotherapeutics 15(2):391\u2013401. https:\/\/doi.org\/10.1007\/s13311-018-0614-7","journal-title":"Neurotherapeutics"},{"issue":"Suppl 1","key":"4438_CR236","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1038\/sj.bjp.0706458","volume":"147","author":"S Moncada","year":"2006","unstructured":"Moncada S, Higgs EA (2006) The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147(Suppl 1):S193-201. https:\/\/doi.org\/10.1038\/sj.bjp.0706458","journal-title":"Br J Pharmacol"},{"key":"4438_CR237","first-page":"124","volume":"29","author":"JE Palmer","year":"2009","unstructured":"Palmer JE, Guillard FL, Laurijssens BE, Wentz AL, Dixon RM, Williams PM (2009) A randomised, single-blind, placebo-controlled, adaptive clinical trial of GW274150, a selective iNOS inhibitor, in the treatment of acute migraine. Cephalalgia 29:124","journal-title":"Cephalalgia"},{"issue":"12","key":"4438_CR238","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1177\/0333102410370875","volume":"30","author":"HO H\u00f8ivik","year":"2010","unstructured":"H\u00f8ivik HO, Laurijssens BE, Harnisch LO, Twomey CK, Dixon RM, Kirkham AJ, Williams PM, Wentz AL, Lunnon MW (2010) Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache. Cephalalgia 30(12):1458\u20131467. https:\/\/doi.org\/10.1177\/0333102410370875","journal-title":"Cephalalgia"},{"issue":"1","key":"4438_CR239","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/sj.bjp.0704842","volume":"137","author":"S Akerman","year":"2002","unstructured":"Akerman S, Williamson DJ, Kaube H, Goadsby PJ (2002) Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol 137(1):62\u201368. https:\/\/doi.org\/10.1038\/sj.bjp.0704842","journal-title":"Br J Pharmacol"},{"key":"4438_CR240","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/1-59259-749-1:1","volume":"100","author":"B Hemmens","year":"1998","unstructured":"Hemmens B, Mayer B (1998) Enzymology of nitric oxide synthases. Methods Mol Biol 100:1\u201332. https:\/\/doi.org\/10.1385\/1-59259-749-1:1","journal-title":"Methods Mol Biol"},{"issue":"5","key":"4438_CR241","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/10641969309041644","volume":"15","author":"AO el Karib","year":"1993","unstructured":"el Karib AO, Sheng J, Betz AL, Malvin RL (1993) The central effects of a nitric oxide synthase inhibitor (N\u03c9-omega-nitro-L-arginine) on blood pressure and plasma renin. Clin Exp Hypertens 15(5):819\u2013832. https:\/\/doi.org\/10.3109\/10641969309041644","journal-title":"Clin Exp Hypertens"},{"issue":"10","key":"4438_CR242","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1097\/HJH.0b013e32832e8ddf","volume":"27","author":"N Toda","year":"2009","unstructured":"Toda N, Ayajiki K, Okamura T (2009) Control of systemic and pulmonary blood pressure by nitric oxide formed through neuronal nitric oxide synthase. J Hypertens 27(10):1929\u20131940. https:\/\/doi.org\/10.1097\/HJH.0b013e32832e8ddf","journal-title":"J Hypertens"},{"issue":"1","key":"4438_CR243","first-page":"343","volume":"262","author":"H Togashi","year":"1992","unstructured":"Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R (1992) A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 262(1):343\u2013347","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"4438_CR244","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/0333102412466967","volume":"33","author":"DK Bhatt","year":"2013","unstructured":"Bhatt DK, Gupta S, Jansen-Olesen I, Andrews JS, Olesen J (2013) NXN-188, a selective nNOS inhibitor and a 5-HT1B\/1D receptor agonist, inhibits CGRP release in preclinical migraine models. Cephalalgia 33(2):87\u2013100. https:\/\/doi.org\/10.1177\/0333102412466967","journal-title":"Cephalalgia"},{"issue":"5","key":"4438_CR245","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/01.anes.0000287213.98020.b6","volume":"107","author":"N Toda","year":"2007","unstructured":"Toda N, Toda H, Hatano Y (2007) Nitric oxide: involvement in the effects of anesthetic agents. Anesthesiology 107(5):822\u2013842. https:\/\/doi.org\/10.1097\/01.anes.0000287213.98020.b6","journal-title":"Anesthesiology"},{"issue":"4","key":"4438_CR246","first-page":"5004","volume":"8","author":"YK Deng","year":"2015","unstructured":"Deng YK, Ding JF, Liu J, Yang YY (2015) Analgesic effects of melatonin on post-herpetic neuralgia. Int J Clin Exp Med 8(4):5004\u20135009","journal-title":"Int J Clin Exp Med"},{"key":"4438_CR247","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neulet.2015.02.006","volume":"590","author":"JQ Chen","year":"2015","unstructured":"Chen JQ, Zeng YM, Dai TJ, Tang QF (2015) Intrathecal L-arginine reduces the antinociception of sevoflurane in formalin-induced pain in rats. Neurosci Lett 590:156\u2013160. https:\/\/doi.org\/10.1016\/j.neulet.2015.02.006","journal-title":"Neurosci Lett"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-022-04438-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-022-04438-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T03:51:15Z","timestamp":1661226675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-022-04438-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":247,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["4438"],"URL":"https:\/\/doi.org\/10.1007\/s11010-022-04438-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares that he has no conflicts of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}